| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 EPHA6 RPS6KA5 SGK1 IRAK2 ALPK1 STK32C MAST2 SGK3 EGFR PRKACG PRKCB PRKCG PKN2 TAF1L MAST3 EPHA5 EPHA7 EPHB1 | 3.64e-13 | 600 | 114 | 23 | GO:0004672 |
| GeneOntologyMolecularFunction | kinase activity | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 EPHA6 RPS6KA5 SGK1 IRAK2 ALPK1 STK32C MAST2 TRRAP SGK3 EGFR PIK3R1 PRKACG PRKCB PRKCG PKN2 TAF1L MAST3 EPHA5 EPHA7 EPHB1 | 9.97e-13 | 764 | 114 | 25 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 EPHA6 RPS6KA5 SGK1 IRAK2 ALPK1 STK32C MAST2 SGK3 EGFR PIK3R1 PRKACG PRKCB PRKCG PKN2 TAF1L MAST3 EPHA5 EPHA7 EPHB1 | 1.49e-12 | 709 | 114 | 24 | GO:0016773 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 3.39e-12 | 65 | 114 | 10 | GO:0004714 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 7.81e-12 | 19 | 114 | 7 | GO:0005003 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB2 EPHB3 EPHB4 PARP11 ERBB3 ERBB4 EPHA6 RPS6KA5 SGK1 IRAK2 ALPK1 STK32C MAST2 TRRAP SGK3 EGFR PIK3R1 PRKACG PRKCB PRKCG PKN2 TAF1L MAST3 EPHA5 EPHA7 EPHB1 | 1.37e-11 | 938 | 114 | 26 | GO:0016772 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 5.38e-11 | 85 | 114 | 10 | GO:0019199 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 1.46e-10 | 15 | 114 | 6 | GO:0005005 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 EPHA6 RPS6KA5 EGFR EPHA5 EPHA7 EPHB1 | 6.86e-10 | 145 | 114 | 11 | GO:0004713 |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 6.92e-07 | 13 | 114 | 4 | GO:0008046 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | RPS6KA5 SGK1 ALPK1 STK32C MAST2 SGK3 EGFR PRKACG PRKCB PRKCG PKN2 TAF1L MAST3 | 1.62e-06 | 446 | 114 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | protein serine kinase activity | RPS6KA5 SGK1 ALPK1 STK32C MAST2 SGK3 PRKACG PRKCB PRKCG PKN2 MAST3 | 7.45e-06 | 363 | 114 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 6.30e-05 | 14 | 114 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB2 EPHB3 EPHB4 TSPAN12 ERBB3 ERBB4 EPHA6 SIGMAR1 TAS1R3 CASR CHRNA3 CHRNB2 ANTXRL P2RX7 EGFR TLR2 S1PR4 EPHA5 EPHA7 EPHB1 | 7.56e-05 | 1353 | 114 | 20 | GO:0004888 |
| GeneOntologyMolecularFunction | chloride channel regulator activity | 7.84e-05 | 15 | 114 | 3 | GO:0017081 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 9.61e-05 | 16 | 114 | 3 | GO:0004697 | |
| GeneOntologyMolecularFunction | neuregulin receptor activity | 9.66e-05 | 3 | 114 | 2 | GO:0038131 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1C CACNA1D CACNA1S ANO9 CHRNA3 CHRNB2 P2RX7 KCNQ3 KCNAB3 | 1.28e-04 | 334 | 114 | 9 | GO:0022836 |
| GeneOntologyMolecularFunction | epidermal growth factor receptor activity | 1.92e-04 | 4 | 114 | 2 | GO:0005006 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.92e-04 | 20 | 114 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.24e-04 | 21 | 114 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 3.19e-04 | 5 | 114 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | neuregulin binding | 4.77e-04 | 6 | 114 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | ErbB-3 class receptor binding | 4.77e-04 | 6 | 114 | 2 | GO:0043125 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 6.66e-04 | 7 | 114 | 2 | GO:0005004 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 7.19e-04 | 187 | 114 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 7.93e-04 | 343 | 114 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | phosphatase binding | 8.06e-04 | 264 | 114 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1C CACNA1D CACNA1S ANO9 CHRNA3 CHRNB2 P2RX7 KCNQ3 KCNAB3 | 1.28e-03 | 459 | 114 | 9 | GO:0005216 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.31e-03 | 210 | 114 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 1.72e-03 | 11 | 114 | 2 | GO:0031956 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 1.77e-03 | 42 | 114 | 3 | GO:0051721 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.81e-03 | 152 | 114 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.89e-03 | 43 | 114 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.02e-03 | 156 | 114 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | histone H3 kinase activity | 2.05e-03 | 12 | 114 | 2 | GO:0140996 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.08e-03 | 230 | 114 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.30e-03 | 46 | 114 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 2.38e-03 | 162 | 114 | 5 | GO:0099106 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 2.42e-03 | 13 | 114 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 3.09e-03 | 172 | 114 | 5 | GO:0044325 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1C CACNA1D CACNA1S ANO9 CHRNA3 CHRNB2 P2RX7 KCNQ3 KCNAB3 | 3.16e-03 | 525 | 114 | 9 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1C CACNA1D CACNA1S ANO9 CHRNA3 CHRNB2 P2RX7 KCNQ3 KCNAB3 | 3.20e-03 | 526 | 114 | 9 | GO:0022803 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 3.23e-03 | 15 | 114 | 2 | GO:0016725 | |
| GeneOntologyMolecularFunction | channel regulator activity | 3.24e-03 | 174 | 114 | 5 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 3.49e-03 | 177 | 114 | 5 | GO:0141108 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 3.64e-03 | 54 | 114 | 3 | GO:0005246 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.68e-03 | 16 | 114 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.93e-03 | 182 | 114 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.11e-03 | 184 | 114 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 4.15e-03 | 17 | 114 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 4.24e-03 | 57 | 114 | 3 | GO:0015459 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1C CACNA1D CACNA1S SLC47A2 CHRNA3 NDUFS3 CHRNB2 P2RX7 KCNQ3 KCNAB3 | 4.73e-03 | 664 | 114 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1C CACNA1D CACNA1S ANO9 SLC47A2 CHRNA3 NDUFS3 CHRNB2 P2RX7 KCNQ3 KCNAB3 | 5.68e-03 | 793 | 114 | 11 | GO:0015075 |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 1.65e-08 | 54 | 112 | 7 | GO:0048013 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | AKAP6 EPHB2 EPHB4 CACNA1C CACNA1D ERBB3 ERBB4 RPS6KA5 SGK1 IRAK2 XDH CASR TRIM68 CHI3L1 CHRNA3 TRIM52 STAT1 P2RX7 EGFR SERINC1 TLR2 LRP1 WDR41 EPHA5 | 5.73e-07 | 1430 | 112 | 24 | GO:0044093 |
| GeneOntologyBiologicalProcess | central nervous system projection neuron axonogenesis | 7.73e-07 | 32 | 112 | 5 | GO:0021952 | |
| GeneOntologyBiologicalProcess | secretion | CACNA1C CACNA1D ERBB3 ERBB4 SGK1 XDH CASR STEAP2 ACE CHRNA3 CHRNB2 P2RX7 EGFR TLR2 LRP1 KCNQ3 PRKCB PRKCG ILDR1 WDR41 EPHA5 | 2.26e-06 | 1221 | 112 | 21 | GO:0046903 |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB2 EPHB3 ERBB4 ACE CLDN8 CHRNB2 PIK3R1 TLR2 LRP1 LRP4 ILDR1 PKN2 EPHA7 EPHB1 | 2.53e-06 | 569 | 112 | 14 | GO:0034329 |
| GeneOntologyBiologicalProcess | optic nerve morphogenesis | 3.08e-06 | 6 | 112 | 3 | GO:0021631 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | AKAP6 CACNA1C CACNA1S SGK1 CASR TRIM68 LCAT ACE STAT1 CHRNB2 P2RX7 EGFR PIK3R1 TLR2 KCNQ3 PRKCB PYGM PRKCG EPHA5 | 3.46e-06 | 1048 | 112 | 19 | GO:0014070 |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 3.52e-06 | 43 | 112 | 5 | GO:0021955 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB2 EPHB3 CACNA1S ERBB4 RPS6KA5 SPG11 ACE CLDN8 CHRNB2 PIK3R1 TLR2 LRP1 LRP4 ILDR1 PKN2 EPHA5 EPHA7 EPHB1 | 4.97e-06 | 974 | 112 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of secretion | CACNA1C CACNA1D ERBB3 SGK1 CASR CHRNA3 CHRNB2 P2RX7 EGFR TLR2 LRP1 PRKCB PRKCG ILDR1 WDR41 EPHA5 | 6.74e-06 | 801 | 112 | 16 | GO:0051046 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 6.84e-06 | 307 | 112 | 10 | GO:0018105 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB2 EPHB3 EPHA6 RPS6KA5 SGK1 SPG11 DSCAML1 CHRNA3 CHRNB2 KIAA0319 EGFR LRP1 LRP4 EPHA5 EPHA7 EPHB1 | 6.84e-06 | 802 | 112 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 7.24e-06 | 309 | 112 | 10 | GO:1901888 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 8.05e-06 | 24 | 112 | 4 | GO:0031290 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB2 EPHB3 EPHA6 RPS6KA5 SGK1 SPG11 DSCAML1 CHRNA3 CHRNB2 KIAA0319 EGFR LRP1 LRP4 EPHA5 EPHA7 EPHB1 | 8.90e-06 | 819 | 112 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 9.56e-06 | 319 | 112 | 10 | GO:0018209 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB2 EPHB3 EPHA6 RPS6KA5 SGK1 SPG11 DSCAML1 CHRNA3 CHRNB2 KIAA0319 EGFR LRP1 LRP4 EPHA5 EPHA7 EPHB1 | 9.89e-06 | 826 | 112 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 1.09e-05 | 194 | 112 | 8 | GO:0050714 | |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB2 EPHB3 EPHA6 RPS6KA5 SPG11 DSCAML1 CHRNB2 KIAA0319 LRP1 LRP4 EPHA5 EPHA7 EPHB1 | 1.24e-05 | 566 | 112 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 EPHA6 XDH CHRNA3 EGFR PIK3R1 LRP1 PRKCB EPHA5 EPHA7 EPHB1 | 1.26e-05 | 747 | 112 | 15 | GO:0007169 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.27e-05 | 198 | 112 | 8 | GO:0048813 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB2 EPHB3 EPHA6 RPS6KA5 SGK1 SPG11 DSCAML1 CHRNA3 CHRNB2 KIAA0319 LRP1 LRP4 EPHA5 EPHA7 EPHB1 | 1.28e-05 | 748 | 112 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.47e-05 | 202 | 112 | 8 | GO:0051963 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB2 EPHB3 EPHA6 RPS6KA5 SGK1 HLA-E GPRIN3 SPG11 GPRIN1 DSCAML1 CHRNA3 CHRNB2 KIAA0319 EGFR LRP1 LRP4 GPRIN2 EPHA5 EPHA7 EPHB1 | 1.78e-05 | 1285 | 112 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | EPHB2 ERBB4 RPS6KA5 SGK1 STK32C CHI3L1 MAST2 ACE P3H4 SGK3 EGFR LRP4 PRKCB PRKCG PKN2 MAST3 EPHA7 | 2.02e-05 | 976 | 112 | 17 | GO:0018193 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | AKAP6 GDF5 ERBB3 ERBB4 IRAK2 XDH CASR TRIM68 ALPK1 CHI3L1 TRIM52 KIAA0319 P2RX7 EGFR PIK3R1 TLR2 LRP1 LRP4 PRKCB MAPKBP1 | 2.08e-05 | 1299 | 112 | 20 | GO:1902533 |
| GeneOntologyBiologicalProcess | positive regulation of peptide hormone secretion | 2.40e-05 | 157 | 112 | 7 | GO:0090277 | |
| GeneOntologyBiologicalProcess | micturition | 2.49e-05 | 11 | 112 | 3 | GO:0060073 | |
| GeneOntologyBiologicalProcess | axon guidance | 2.57e-05 | 285 | 112 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.64e-05 | 286 | 112 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide secretion | 2.82e-05 | 161 | 112 | 7 | GO:0002793 | |
| GeneOntologyBiologicalProcess | nerve development | 2.88e-05 | 109 | 112 | 6 | GO:0021675 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 3.19e-05 | 67 | 112 | 5 | GO:0099171 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 EPHB3 EPHA6 RPS6KA5 SGK1 HLA-E GPRIN3 SPG11 GPRIN1 DSCAML1 CHRNA3 CHRNB2 KIAA0319 EGFR LRP1 LRP4 KCNQ3 GPRIN2 EPHA5 EPHA7 EPHB1 | 3.55e-05 | 1463 | 112 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | axon development | EPHB2 EPHB3 EPHA6 RPS6KA5 SPG11 DSCAML1 CHRNB2 KIAA0319 LRP1 LRP4 EPHA5 EPHA7 EPHB1 | 4.59e-05 | 642 | 112 | 13 | GO:0061564 |
| GeneOntologyBiologicalProcess | synapse assembly | 4.70e-05 | 308 | 112 | 9 | GO:0007416 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 4.77e-05 | 385 | 112 | 10 | GO:0070372 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | CACNA1C CACNA1D CASR CHRNA3 CHRNB2 P2RX7 EGFR TLR2 LRP1 PRKCB PRKCG ILDR1 WDR41 EPHA5 | 4.82e-05 | 740 | 112 | 14 | GO:1903530 |
| GeneOntologyBiologicalProcess | membrane depolarization | 5.19e-05 | 121 | 112 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | AKAP6 EPHB2 CACNA1S SGK1 CASR ACE CHRNA3 STAT1 CHRNB2 TMX1 P2RX7 EGFR PIK3R1 TLR2 LRP1 KCNQ3 PRKCB PYGM PRKCG | 5.20e-05 | 1272 | 112 | 19 | GO:1901698 |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | AKAP6 EPHB2 CACNA1S SGK1 ACE CHRNA3 STAT1 CHRNB2 P2RX7 PIK3R1 TLR2 LRP1 KCNQ3 PRKCB | 5.72e-05 | 752 | 112 | 14 | GO:1901699 |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 6.16e-05 | 319 | 112 | 9 | GO:0051222 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | EPHB2 ERBB4 SPG11 ACE CHRNA3 CHRNB2 P2RX7 EGFR KCNQ3 PRKCB PRKCG EPHA7 EPHB1 | 6.37e-05 | 663 | 112 | 13 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | EPHB2 ERBB4 SPG11 ACE CHRNA3 CHRNB2 P2RX7 EGFR KCNQ3 PRKCB PRKCG EPHA7 EPHB1 | 6.47e-05 | 664 | 112 | 13 | GO:0099177 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | EPHB2 EPHB3 EPHB4 GDF5 ERBB3 ERBB4 EPHA6 XDH CHRNA3 KIAA0319 EGFR PIK3R1 LRP1 LRP4 PRKCB EPHA5 EPHA7 EPHB1 | 6.85e-05 | 1186 | 112 | 18 | GO:0007167 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | AKAP6 CACNA1C CACNA1D CACNA1S SGK1 CASR MINPP1 STEAP2 ACE P2RX7 PIK3R1 LRP1 PRKCB PYGM EPHA5 | 6.91e-05 | 866 | 112 | 15 | GO:0055082 |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | CACNA1C CACNA1D CASR CHRNB2 P2RX7 EGFR TLR2 LRP1 PRKCB ILDR1 | 7.13e-05 | 404 | 112 | 10 | GO:1903532 |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 7.15e-05 | 41 | 112 | 4 | GO:1901889 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | AKAP6 EPHB2 CACNA1C CACNA1D ERBB3 ERBB4 SGK1 CASR SIRPB1 CHRNB2 P2RX7 EGFR PIK3R1 TLR2 LRP1 PRKCB ILDR1 | 7.24e-05 | 1081 | 112 | 17 | GO:0051050 |
| GeneOntologyBiologicalProcess | canonical NF-kappaB signal transduction | 7.98e-05 | 330 | 112 | 9 | GO:0007249 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane depolarization | 8.29e-05 | 16 | 112 | 3 | GO:1904181 | |
| GeneOntologyBiologicalProcess | synaptic transmission involved in micturition | 8.74e-05 | 3 | 112 | 2 | GO:0060084 | |
| GeneOntologyBiologicalProcess | synapse organization | EPHB2 EPHB3 CACNA1S ERBB4 RPS6KA5 SPG11 CHRNB2 PIK3R1 TLR2 LRP4 EPHA5 EPHA7 EPHB1 | 8.85e-05 | 685 | 112 | 13 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | EPHB2 CACNA1C CACNA1D ERBB4 CASR P2RX7 EGFR PIK3R1 TLR2 LRP1 LRP4 PRKCB | 8.92e-05 | 591 | 112 | 12 | GO:1903829 |
| GeneOntologyBiologicalProcess | dendrite development | 8.95e-05 | 335 | 112 | 9 | GO:0016358 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 9.44e-05 | 418 | 112 | 10 | GO:0070371 | |
| GeneOntologyBiologicalProcess | calcium ion transport | AKAP6 CACNA1C CACNA1D CACNA1S CASR SPG11 ACE CHRNB2 TMX1 P2RX7 PRKCB | 1.03e-04 | 509 | 112 | 11 | GO:0006816 |
| GeneOntologyBiologicalProcess | action potential | 1.15e-04 | 201 | 112 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 1.23e-04 | 273 | 112 | 8 | GO:0034764 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 1.25e-04 | 350 | 112 | 9 | GO:0050708 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone secretion | 1.30e-04 | 205 | 112 | 7 | GO:0046887 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion | CACNA1C CACNA1D CASR CHRNB2 P2RX7 EGFR TLR2 LRP1 PRKCB ILDR1 | 1.31e-04 | 435 | 112 | 10 | GO:0051047 |
| GeneOntologyBiologicalProcess | chemical homeostasis | AKAP6 CACNA1C CACNA1D CACNA1S ERBB4 SGK1 CASR MINPP1 LCAT STEAP2 ACE P2RX7 PIK3R1 PRKACG LRP1 PRKCB PYGM EPHA5 | 1.32e-04 | 1249 | 112 | 18 | GO:0048878 |
| GeneOntologyBiologicalProcess | regulation of peptide hormone secretion | 1.36e-04 | 277 | 112 | 8 | GO:0090276 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | AKAP6 EPHB2 CACNA1C CACNA1D CACNA1S ANO9 SGK1 CASR SPG11 STEAP2 ACE SLC47A2 CHRNA3 CHRNB2 TMX1 P2RX7 KCNQ3 PRKCB KCNAB3 | 1.44e-04 | 1374 | 112 | 19 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | EPHB2 EPHB3 SGK1 ACE KIAA0319 EGFR PIK3R1 TLR2 LRP1 LRP4 EPHA7 EPHB1 | 1.51e-04 | 625 | 112 | 12 | GO:0051960 |
| GeneOntologyBiologicalProcess | regulation of peptide transport | 1.54e-04 | 282 | 112 | 8 | GO:0090087 | |
| GeneOntologyBiologicalProcess | regulation of peptide secretion | 1.54e-04 | 282 | 112 | 8 | GO:0002791 | |
| GeneOntologyBiologicalProcess | export from cell | CACNA1C CACNA1D CASR STEAP2 SLC47A2 CHRNA3 CHRNB2 P2RX7 EGFR TLR2 LRP1 KCNQ3 PRKCB PRKCG ILDR1 WDR41 EPHA5 | 1.58e-04 | 1153 | 112 | 17 | GO:0140352 |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in regeneration | 1.74e-04 | 4 | 112 | 2 | GO:0048690 | |
| GeneOntologyBiologicalProcess | regulation of system process | AKAP6 CACNA1C CACNA1D CACNA1S SGK1 CASR ACE TRIP10 CHRNA3 CHRNB2 NUP155 EGFR PIK3R1 | 1.75e-04 | 734 | 112 | 13 | GO:0044057 |
| GeneOntologyBiologicalProcess | calcium ion import | 1.96e-04 | 98 | 112 | 5 | GO:0070509 | |
| GeneOntologyBiologicalProcess | secretion by cell | CACNA1C CACNA1D CASR STEAP2 CHRNA3 CHRNB2 P2RX7 EGFR TLR2 LRP1 KCNQ3 PRKCB PRKCG ILDR1 WDR41 EPHA5 | 2.01e-04 | 1064 | 112 | 16 | GO:0032940 |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 2.06e-04 | 99 | 112 | 5 | GO:0021954 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 2.09e-04 | 375 | 112 | 9 | GO:0007162 | |
| GeneOntologyBiologicalProcess | optic nerve development | 2.23e-04 | 22 | 112 | 3 | GO:0021554 | |
| GeneOntologyBiologicalProcess | signal release | CACNA1C CACNA1D CASR CHRNA3 CHRNB2 P2RX7 EGFR LRP1 PRKCB PRKCG ILDR1 EPHA5 | 2.26e-04 | 653 | 112 | 12 | GO:0023061 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB2 EPHB3 EPHA6 RPS6KA5 SGK1 SPG11 DSCAML1 CHRNA3 CHRNB2 KIAA0319 P2RX7 EGFR LRP1 LRP4 EPHA5 EPHA7 EPHB1 | 2.39e-04 | 1194 | 112 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 2.49e-04 | 228 | 112 | 7 | GO:0046777 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 2.64e-04 | 387 | 112 | 9 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of D-glucose transmembrane transport | 2.71e-04 | 105 | 112 | 5 | GO:0010827 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | AKAP6 CACNA1C CACNA1D CACNA1S SGK1 CASR MINPP1 STEAP2 ACE P2RX7 PIK3R1 LRP1 PRKCB PYGM EPHA5 | 2.71e-04 | 981 | 112 | 15 | GO:0019725 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 2.89e-04 | 5 | 112 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | hindbrain tangential cell migration | 2.89e-04 | 5 | 112 | 2 | GO:0021934 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 2.89e-04 | 5 | 112 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | regulation of sprouting of injured axon | 2.89e-04 | 5 | 112 | 2 | GO:0048686 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 2.94e-04 | 166 | 112 | 6 | GO:0014074 | |
| GeneOntologyBiologicalProcess | regulation of growth | AKAP6 CACNA1C GDF5 ERBB4 SGK1 TRIP10 NDUFS3 SGK3 KIAA0319 EGFR LRP1 PRKCB EPHA7 | 3.05e-04 | 777 | 112 | 13 | GO:0040008 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | AKAP6 EPHB2 CACNA1C CACNA1D SGK1 CASR SPG11 ACE TMX1 P2RX7 KCNAB3 | 3.05e-04 | 577 | 112 | 11 | GO:0043269 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 3.06e-04 | 395 | 112 | 9 | GO:0050803 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 3.23e-04 | 169 | 112 | 6 | GO:0010977 | |
| GeneOntologyBiologicalProcess | metal ion transport | AKAP6 CACNA1C CACNA1D CACNA1S SGK1 CASR SPG11 STEAP2 ACE CHRNB2 TMX1 P2RX7 KCNQ3 PRKCB KCNAB3 | 3.32e-04 | 1000 | 112 | 15 | GO:0030001 |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 3.54e-04 | 403 | 112 | 9 | GO:1904951 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 3.57e-04 | 493 | 112 | 10 | GO:0010959 | |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 3.61e-04 | 62 | 112 | 4 | GO:0050771 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | AKAP6 EPHB2 CACNA1C CACNA1D ERBB3 ERBB4 ACE P2RX7 PIK3R1 PRKCB KCNAB3 | 3.63e-04 | 589 | 112 | 11 | GO:0034762 |
| GeneOntologyBiologicalProcess | response to lipid | EPHB2 SGK1 IRAK2 CASR SIRPB1 TRIM68 LCAT ACE STAT1 P2RX7 EGFR PIK3R1 TLR2 PRKCB ILDR1 EPHA5 | 3.79e-04 | 1126 | 112 | 16 | GO:0033993 |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 3.85e-04 | 323 | 112 | 8 | GO:0051924 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 4.09e-04 | 326 | 112 | 8 | GO:1903522 | |
| GeneOntologyBiologicalProcess | ERBB2 signaling pathway | 4.15e-04 | 27 | 112 | 3 | GO:0038128 | |
| GeneOntologyCellularComponent | cell surface | EPHB2 CACNA1C CACNA1D HLA-E CASR SIRPB1 LCT ACE DSCAML1 CHRNB2 ANTXRL FCRL1 P2RX7 EGFR BTNL2 TLR2 LRP1 LRP4 KCNQ3 LY75 EPHA5 | 4.66e-07 | 1111 | 113 | 21 | GO:0009986 |
| GeneOntologyCellularComponent | dendrite | EPHB2 EPHB3 CACNA1C CACNA1D CACNA1S ERBB4 EPHA6 SPG11 CHRNA3 STAT1 LRP1 LRP4 KCNQ3 PRKCG EPHA5 EPHA7 EPHB1 | 3.56e-06 | 858 | 113 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB2 EPHB3 CACNA1C CACNA1D CACNA1S ERBB4 EPHA6 SPG11 CHRNA3 STAT1 LRP1 LRP4 KCNQ3 PRKCG EPHA5 EPHA7 EPHB1 | 3.67e-06 | 860 | 113 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 EPHB3 CACNA1C CACNA1D CACNA1S ERBB4 EPHA6 CASR SPG11 RRM1 CHRNA3 STAT1 P2RX7 LRP1 LRP4 KCNQ3 PRKCG EPHA5 EPHA7 EPHB1 | 8.68e-06 | 1228 | 113 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | membrane raft | AKAP6 CACNA1C ERBB4 HLA-E CHRNA3 CHRNB2 EGFR TLR2 LRP4 EPHB1 | 2.74e-05 | 362 | 113 | 10 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | AKAP6 CACNA1C ERBB4 HLA-E CHRNA3 CHRNB2 EGFR TLR2 LRP4 EPHB1 | 2.87e-05 | 364 | 113 | 10 | GO:0098857 |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 3.27e-05 | 12 | 113 | 3 | GO:1990454 | |
| GeneOntologyCellularComponent | synaptic membrane | EPHB2 CACNA1C CACNA1D ERBB3 ERBB4 SIGMAR1 CHRNA3 CHRNB2 LRP1 LRP4 PRKCG EPHA7 | 7.54e-05 | 583 | 113 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | axon | EPHB2 CACNA1C SIGMAR1 CASR SPG11 GPRIN1 DSCAML1 STAT1 P2RX7 LRP1 KCNQ3 PRKCB PRKCG EPHA5 EPHB1 | 9.08e-05 | 891 | 113 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.12e-04 | 201 | 113 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | plasma membrane raft | 1.49e-04 | 147 | 113 | 6 | GO:0044853 | |
| GeneOntologyCellularComponent | receptor complex | EPHB4 ERBB3 ERBB4 TAS1R3 LRP1B CHRNA3 CHRNB2 EGFR TLR2 LRP1 EPHA5 | 3.13e-04 | 581 | 113 | 11 | GO:0043235 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1C CACNA1D CACNA1S ERBB3 HLA-E CHRNA3 CHRNB2 EGFR TLR2 ABCD4 LRP1 KCNQ3 KCNAB3 | 3.23e-04 | 785 | 113 | 13 | GO:0098797 |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.56e-04 | 405 | 113 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | cell body | EPHB2 CACNA1C CACNA1D ERBB4 CASR RRM1 CHRNA3 P2RX7 TLR2 LRP1 LRP4 KCNQ3 EPHA5 EPHA7 | 4.87e-04 | 929 | 113 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | external side of plasma membrane | 5.16e-04 | 519 | 113 | 10 | GO:0009897 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | AKAP6 CACNA1C CACNA1D CACNA1S CHRNA3 NDUFS3 CHRNB2 ABCD4 KCNQ3 KCNAB3 | 5.47e-04 | 523 | 113 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | neuronal cell body | EPHB2 CACNA1C CACNA1D ERBB4 CASR RRM1 CHRNA3 P2RX7 LRP1 LRP4 KCNQ3 EPHA5 EPHA7 | 5.79e-04 | 835 | 113 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | calcium channel complex | 6.61e-04 | 73 | 113 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | transporter complex | AKAP6 CACNA1C CACNA1D CACNA1S CHRNA3 NDUFS3 CHRNB2 ABCD4 KCNQ3 KCNAB3 | 8.06e-04 | 550 | 113 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | T-tubule | 8.90e-04 | 79 | 113 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.04e-03 | 378 | 113 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.33e-03 | 88 | 113 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | AKAP6 SGK1 TRIM68 CHI3L1 TRIP10 STAT1 HHATL EGFR PIK3R1 LRP1 PRKCG PKN2 EPHA5 | 1.61e-03 | 934 | 113 | 13 | GO:0048471 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.64e-03 | 157 | 113 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.65e-03 | 503 | 113 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | cation channel complex | 1.76e-03 | 235 | 113 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.97e-03 | 46 | 113 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.14e-03 | 523 | 113 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | anchoring junction | AKAP6 SIGMAR1 MAST2 CLDN8 P2RX7 EGFR SH3PXD2A PIK3R1 LRP1 PRKCG ILDR1 PKN2 EPHA5 | 2.36e-03 | 976 | 113 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | membrane protein complex | AKAP6 CACNA1C CACNA1D CACNA1S ERBB3 HLA-E CHRNA3 NDUFS3 CHRNB2 PIGC EGFR PIK3R1 TLR2 ABCD4 LRP1 KCNQ3 KCNAB3 | 2.81e-03 | 1498 | 113 | 17 | GO:0098796 |
| GeneOntologyCellularComponent | basal plasma membrane | 3.14e-03 | 354 | 113 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | postsynaptic density | 3.14e-03 | 451 | 113 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | neuromuscular junction | 3.21e-03 | 112 | 113 | 4 | GO:0031594 | |
| GeneOntologyCellularComponent | nuclear envelope | 3.38e-03 | 560 | 113 | 9 | GO:0005635 | |
| GeneOntologyCellularComponent | postsynapse | EPHB2 CACNA1C CACNA1S ERBB3 ERBB4 SIGMAR1 CHRNA3 CHRNB2 P2RX7 LRP1 LRP4 PRKCG EPHA7 | 3.39e-03 | 1018 | 113 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | sarcoplasm | 3.42e-03 | 114 | 113 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 4.19e-03 | 18 | 113 | 2 | GO:0005892 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.40e-03 | 477 | 113 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | basal part of cell | 4.49e-03 | 378 | 113 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 5.93e-03 | 212 | 113 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | cholinergic synapse | 6.23e-03 | 22 | 113 | 2 | GO:0098981 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 6.23e-03 | 22 | 113 | 2 | GO:0098691 | |
| MousePheno | abnormal axon pruning | 1.66e-05 | 8 | 95 | 3 | MP:0008960 | |
| MousePheno | atrial fibrillation | 3.52e-05 | 10 | 95 | 3 | MP:0008543 | |
| MousePheno | abnormal sensory neuron innervation pattern | 3.74e-05 | 92 | 95 | 6 | MP:0000968 | |
| MousePheno | abnormal innervation | 4.98e-05 | 193 | 95 | 8 | MP:0002184 | |
| MousePheno | abnormal macrophage nitric oxide production | 8.28e-05 | 13 | 95 | 3 | MP:0011074 | |
| MousePheno | fibrillation | 1.05e-04 | 14 | 95 | 3 | MP:0006109 | |
| MousePheno | decreased aerobic running capacity | 1.30e-04 | 15 | 95 | 3 | MP:0003061 | |
| Domain | Kinase-like_dom | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 EPHA6 RPS6KA5 SGK1 IRAK2 ALPK1 STK32C MAST2 TRRAP SGK3 EGFR PRKACG PRKCB PRKCG PKN2 MAST3 EPHA5 EPHA7 EPHB1 | 1.72e-13 | 542 | 114 | 23 | IPR011009 |
| Domain | PROTEIN_KINASE_ATP | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 EPHA6 RPS6KA5 SGK1 IRAK2 STK32C MAST2 SGK3 EGFR PRKACG PRKCB PRKCG PKN2 MAST3 EPHA5 EPHA7 EPHB1 | 5.27e-13 | 459 | 114 | 21 | PS00107 |
| Domain | RECEPTOR_TYR_KIN_V_2 | 8.68e-13 | 14 | 114 | 7 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 8.68e-13 | 14 | 114 | 7 | PS00790 | |
| Domain | Eph_TM | 8.68e-13 | 14 | 114 | 7 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 8.68e-13 | 14 | 114 | 7 | IPR001426 | |
| Domain | EPH_lbd | 8.68e-13 | 14 | 114 | 7 | SM00615 | |
| Domain | Ephrin_lbd | 8.68e-13 | 14 | 114 | 7 | PF01404 | |
| Domain | EphA2_TM | 8.68e-13 | 14 | 114 | 7 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 8.68e-13 | 14 | 114 | 7 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 8.68e-13 | 14 | 114 | 7 | IPR001090 | |
| Domain | EPH_LBD | 8.68e-13 | 14 | 114 | 7 | PS51550 | |
| Domain | Prot_kinase_dom | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 EPHA6 RPS6KA5 SGK1 IRAK2 STK32C MAST2 SGK3 EGFR PRKACG PRKCB PRKCG PKN2 MAST3 EPHA5 EPHA7 EPHB1 | 1.77e-12 | 489 | 114 | 21 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 EPHA6 RPS6KA5 SGK1 IRAK2 STK32C MAST2 SGK3 EGFR PRKACG PRKCB PRKCG PKN2 MAST3 EPHA5 EPHA7 EPHB1 | 2.07e-12 | 493 | 114 | 21 | PS50011 |
| Domain | Growth_fac_rcpt_ | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 EPHA6 LRP1B EGFR LRP1 LRP4 EPHA5 EPHA7 EPHB1 | 1.22e-11 | 156 | 114 | 13 | IPR009030 |
| Domain | AGC-kinase_C | 5.09e-11 | 56 | 114 | 9 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 5.09e-11 | 56 | 114 | 9 | PS51285 | |
| Domain | S_TK_X | 5.09e-11 | 56 | 114 | 9 | SM00133 | |
| Domain | Ephrin_rec_like | 1.15e-10 | 25 | 114 | 7 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.15e-10 | 25 | 114 | 7 | IPR011641 | |
| Domain | Protein_kinase_ATP_BS | EPHB2 EPHB3 EPHB4 ERBB4 EPHA6 RPS6KA5 SGK1 STK32C SGK3 EGFR PRKACG PRKCB PRKCG PKN2 EPHA5 EPHA7 EPHB1 | 1.45e-10 | 379 | 114 | 17 | IPR017441 |
| Domain | TyrKc | 1.46e-10 | 88 | 114 | 10 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.46e-10 | 88 | 114 | 10 | IPR020635 | |
| Domain | Pkinase_C | 1.49e-10 | 42 | 114 | 8 | PF00433 | |
| Domain | PROTEIN_KINASE_TYR | 3.88e-10 | 97 | 114 | 10 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.88e-10 | 97 | 114 | 10 | IPR008266 | |
| Domain | Pkinase_Tyr | 6.44e-09 | 129 | 114 | 10 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.24e-08 | 138 | 114 | 10 | IPR001245 | |
| Domain | Pkinase_C | 9.02e-08 | 37 | 114 | 6 | IPR017892 | |
| Domain | SAM_1 | 1.87e-07 | 68 | 114 | 7 | PF00536 | |
| Domain | GRIN_C | 2.21e-07 | 3 | 114 | 3 | IPR032745 | |
| Domain | GRIN_C | 2.21e-07 | 3 | 114 | 3 | PF15235 | |
| Domain | - | 3.06e-07 | 73 | 114 | 7 | 2.60.120.260 | |
| Domain | Ephrin_rec_like | 4.20e-07 | 11 | 114 | 4 | PF07699 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 8.82e-07 | 4 | 114 | 3 | IPR016245 | |
| Domain | VDCC_L_a1su | 8.82e-07 | 4 | 114 | 3 | IPR005446 | |
| Domain | SAM | 1.11e-06 | 88 | 114 | 7 | SM00454 | |
| Domain | Ldl_recept_b | 1.26e-06 | 14 | 114 | 4 | PF00058 | |
| Domain | LDLRB | 1.26e-06 | 14 | 114 | 4 | PS51120 | |
| Domain | LY | 1.71e-06 | 15 | 114 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.71e-06 | 15 | 114 | 4 | IPR000033 | |
| Domain | Galactose-bd-like | 1.73e-06 | 94 | 114 | 7 | IPR008979 | |
| Domain | SAM_DOMAIN | 1.86e-06 | 95 | 114 | 7 | PS50105 | |
| Domain | FN3 | 2.00e-06 | 185 | 114 | 9 | SM00060 | |
| Domain | SAM | 2.14e-06 | 97 | 114 | 7 | IPR001660 | |
| Domain | - | 3.88e-06 | 106 | 114 | 7 | 1.10.150.50 | |
| Domain | GF_recep_IV | 4.37e-06 | 6 | 114 | 3 | PF14843 | |
| Domain | GF_recep_IV | 4.37e-06 | 6 | 114 | 3 | IPR032778 | |
| Domain | FN3_dom | 5.44e-06 | 209 | 114 | 9 | IPR003961 | |
| Domain | fn3 | 6.80e-06 | 162 | 114 | 8 | PF00041 | |
| Domain | SAM/pointed | 7.48e-06 | 117 | 114 | 7 | IPR013761 | |
| Domain | Furin-like | 7.61e-06 | 7 | 114 | 3 | PF00757 | |
| Domain | Rcpt_L-dom | 7.61e-06 | 7 | 114 | 3 | IPR000494 | |
| Domain | VDCC_a1su_IQ | 7.61e-06 | 7 | 114 | 3 | IPR014873 | |
| Domain | GPHH | 7.61e-06 | 7 | 114 | 3 | PF16905 | |
| Domain | GPHH_dom | 7.61e-06 | 7 | 114 | 3 | IPR031649 | |
| Domain | Furin-like_Cys-rich_dom | 7.61e-06 | 7 | 114 | 3 | IPR006211 | |
| Domain | Recep_L_domain | 7.61e-06 | 7 | 114 | 3 | PF01030 | |
| Domain | Ca_chan_IQ | 7.61e-06 | 7 | 114 | 3 | SM01062 | |
| Domain | - | 7.61e-06 | 7 | 114 | 3 | 3.80.20.20 | |
| Domain | Ca_chan_IQ | 7.61e-06 | 7 | 114 | 3 | PF08763 | |
| Domain | Ser/Thr_kinase_AS | RPS6KA5 SGK1 IRAK2 STK32C MAST2 SGK3 PRKACG PRKCB PRKCG PKN2 MAST3 | 1.19e-05 | 357 | 114 | 11 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | RPS6KA5 SGK1 IRAK2 STK32C MAST2 SGK3 PRKACG PRKCB PRKCG PKN2 MAST3 | 1.35e-05 | 362 | 114 | 11 | PS00108 |
| Domain | Pkinase | RPS6KA5 SGK1 IRAK2 STK32C MAST2 SGK3 PRKACG PRKCB PRKCG PKN2 MAST3 | 2.17e-05 | 381 | 114 | 11 | PF00069 |
| Domain | Ig-like_fold | EPHB2 EPHB3 EPHB4 EPHA6 HLA-E SIRPB1 DSCAML1 KIAA0319 ANTXRL FCRL1 BTNL2 ILDR1 EPHA5 EPHA7 EPHB1 | 2.56e-05 | 706 | 114 | 15 | IPR013783 |
| Domain | VDCCAlpha1 | 2.58e-05 | 10 | 114 | 3 | IPR002077 | |
| Domain | FN3 | 3.03e-05 | 199 | 114 | 8 | PS50853 | |
| Domain | DUF5050 | 3.69e-05 | 2 | 114 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.69e-05 | 2 | 114 | 2 | PF16472 | |
| Domain | GPRIN2-like/GPRIN3 | 3.69e-05 | 2 | 114 | 2 | IPR026646 | |
| Domain | - | EPHB2 EPHB3 EPHB4 EPHA6 HLA-E SIRPB1 DSCAML1 ANTXRL FCRL1 BTNL2 ILDR1 EPHA5 EPHA7 EPHB1 | 5.20e-05 | 663 | 114 | 14 | 2.60.40.10 |
| Domain | S_TKc | RPS6KA5 SGK1 STK32C MAST2 SGK3 PRKACG PRKCB PRKCG PKN2 MAST3 | 7.03e-05 | 359 | 114 | 10 | SM00220 |
| Domain | - | 9.18e-05 | 39 | 114 | 4 | 2.120.10.30 | |
| Domain | CAC1F_C | 1.10e-04 | 3 | 114 | 2 | IPR031688 | |
| Domain | CAC1F_C | 1.10e-04 | 3 | 114 | 2 | PF16885 | |
| Domain | Protein_kinase_C_a/b/g | 1.10e-04 | 3 | 114 | 2 | IPR014375 | |
| Domain | Furin_repeat | 1.69e-04 | 18 | 114 | 3 | IPR006212 | |
| Domain | FU | 1.69e-04 | 18 | 114 | 3 | SM00261 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.76e-04 | 46 | 114 | 4 | IPR011042 | |
| Domain | DUF1908 | 2.20e-04 | 4 | 114 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 2.20e-04 | 4 | 114 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 2.20e-04 | 4 | 114 | 2 | IPR023142 | |
| Domain | - | 2.20e-04 | 4 | 114 | 2 | 1.20.1480.20 | |
| Domain | EGF_2 | 2.22e-04 | 265 | 114 | 8 | PS01186 | |
| Domain | cEGF | 5.20e-04 | 26 | 114 | 3 | IPR026823 | |
| Domain | cEGF | 5.20e-04 | 26 | 114 | 3 | PF12662 | |
| Domain | EGF-like_CS | 1.11e-03 | 261 | 114 | 7 | IPR013032 | |
| Domain | LDLR_class-A_CS | 1.86e-03 | 40 | 114 | 3 | IPR023415 | |
| Domain | WWE | 2.34e-03 | 12 | 114 | 2 | PS50918 | |
| Domain | WWE | 2.34e-03 | 12 | 114 | 2 | PF02825 | |
| Domain | WWE-dom | 2.34e-03 | 12 | 114 | 2 | IPR004170 | |
| Domain | Quinoprot_gluc/sorb_DH | 2.34e-03 | 12 | 114 | 2 | IPR011041 | |
| Domain | Ldl_recept_a | 2.61e-03 | 45 | 114 | 3 | PF00057 | |
| Domain | NCD3G | 2.76e-03 | 13 | 114 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 2.76e-03 | 13 | 114 | 2 | IPR011500 | |
| Domain | - | 2.78e-03 | 46 | 114 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.14e-03 | 48 | 114 | 3 | PS01209 | |
| Domain | GPCR_3_CS | 3.20e-03 | 14 | 114 | 2 | IPR017979 | |
| Domain | LDLRA_2 | 3.33e-03 | 49 | 114 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 3.33e-03 | 49 | 114 | 3 | IPR002172 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 2.48e-08 | 51 | 87 | 7 | M27311 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 5.43e-08 | 34 | 87 | 6 | MM15025 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | CACNA1C CACNA1D CACNA1S ERBB3 ERBB4 P2RX7 EGFR PRKACG PRKCB PRKCG | 1.38e-07 | 178 | 87 | 10 | M2890 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB2 EPHB3 EPHB4 CACNA1C CACNA1D CACNA1S EPHA6 RPS6KA5 DSCAML1 EGFR PIK3R1 PRKACG KCNQ3 EPHA5 EPHA7 EPHB1 | 3.83e-07 | 575 | 87 | 16 | M29853 |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 1.29e-06 | 14 | 87 | 4 | MM14761 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.53e-06 | 92 | 87 | 7 | M27201 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 2.33e-06 | 16 | 87 | 4 | M570 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 2.86e-06 | 65 | 87 | 6 | MM14911 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 3.88e-06 | 18 | 87 | 4 | MM15024 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 4.43e-06 | 40 | 87 | 5 | M62 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 4.48e-06 | 6 | 87 | 3 | M47762 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB2 EPHB3 EPHB4 EPHA6 RPS6KA5 DSCAML1 EGFR PIK3R1 EPHA7 EPHB1 | 4.55e-06 | 261 | 87 | 10 | MM15676 |
| Pathway | REACTOME_EPHRIN_SIGNALING | 4.89e-06 | 19 | 87 | 4 | M27310 | |
| Pathway | BIOCARTA_CREB_PATHWAY | 9.09e-06 | 22 | 87 | 4 | M9070 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 1.10e-05 | 23 | 87 | 4 | M18719 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 1.10e-05 | 23 | 87 | 4 | MM1480 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY | 1.24e-05 | 8 | 87 | 3 | M47479 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.45e-05 | 129 | 87 | 7 | M5539 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 1.57e-05 | 87 | 87 | 6 | M12467 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 1.82e-05 | 26 | 87 | 4 | M29535 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 2.13e-05 | 27 | 87 | 4 | M1909 | |
| Pathway | WP_ERBB_SIGNALING | 2.16e-05 | 92 | 87 | 6 | M39715 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 2.47e-05 | 28 | 87 | 4 | MM1386 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 3.28e-05 | 30 | 87 | 4 | M257 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 3.61e-05 | 11 | 87 | 3 | MM15478 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 3.68e-05 | 101 | 87 | 6 | M1979 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 4.83e-05 | 33 | 87 | 4 | MM14523 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 6.21e-05 | 13 | 87 | 3 | MM15320 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 6.21e-05 | 13 | 87 | 3 | M27729 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 7.63e-05 | 115 | 87 | 6 | M9387 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 7.65e-05 | 37 | 87 | 4 | MM15022 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 7.87e-05 | 14 | 87 | 3 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 7.87e-05 | 14 | 87 | 3 | M47692 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 7.87e-05 | 14 | 87 | 3 | MM14531 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 9.79e-05 | 15 | 87 | 3 | M201 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 9.79e-05 | 15 | 87 | 3 | M47382 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 9.79e-05 | 15 | 87 | 3 | M27608 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 1.04e-04 | 40 | 87 | 4 | M39798 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 1.16e-04 | 381 | 87 | 10 | M48063 | |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 1.27e-04 | 42 | 87 | 4 | M16473 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.27e-04 | 42 | 87 | 4 | M27308 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 1.39e-04 | 43 | 87 | 4 | M39788 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.52e-04 | 44 | 87 | 4 | MM14520 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 1.59e-04 | 83 | 87 | 5 | M39637 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 1.68e-04 | 84 | 87 | 5 | M39839 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 2.39e-04 | 267 | 87 | 8 | M10792 | |
| Pathway | BIOCARTA_CREB_PATHWAY | 2.40e-04 | 20 | 87 | 3 | MM1520 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 2.51e-04 | 50 | 87 | 4 | M553 | |
| Pathway | PID_ECADHERIN_KERATINOCYTE_PATHWAY | 2.79e-04 | 21 | 87 | 3 | M184 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 3.21e-04 | 22 | 87 | 3 | M26929 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 3.38e-04 | 54 | 87 | 4 | M19818 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.68e-04 | 23 | 87 | 3 | M47666 | |
| Pathway | BIOCARTA_ERBB3_PATHWAY | 3.72e-04 | 5 | 87 | 2 | M22018 | |
| Pathway | REACTOME_DISINHIBITION_OF_SNARE_FORMATION | 3.72e-04 | 5 | 87 | 2 | M26920 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 4.18e-04 | 24 | 87 | 3 | M11520 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 4.27e-04 | 367 | 87 | 9 | M48346 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 4.45e-04 | 58 | 87 | 4 | M544 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 4.73e-04 | 25 | 87 | 3 | MM1519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 4.73e-04 | 25 | 87 | 3 | M47948 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 4.73e-04 | 25 | 87 | 3 | M47934 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 5.33e-04 | 26 | 87 | 3 | MM15501 | |
| Pathway | BIOCARTA_ERBB3_PATHWAY | 5.56e-04 | 6 | 87 | 2 | MM1543 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.11e-04 | 63 | 87 | 4 | M11187 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 6.65e-04 | 28 | 87 | 3 | M2529 | |
| Pathway | KEGG_GLIOMA | 6.88e-04 | 65 | 87 | 4 | M1835 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 7.39e-04 | 29 | 87 | 3 | M39616 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 7.39e-04 | 29 | 87 | 3 | M27309 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 7.39e-04 | 29 | 87 | 3 | M27756 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 7.39e-04 | 29 | 87 | 3 | MM1452 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 7.75e-04 | 7 | 87 | 2 | M22043 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 7.75e-04 | 7 | 87 | 2 | M27596 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 7.75e-04 | 7 | 87 | 2 | MM15311 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 7.75e-04 | 7 | 87 | 2 | MM1563 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 7.75e-04 | 7 | 87 | 2 | M47430 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY | 7.75e-04 | 7 | 87 | 2 | M47431 | |
| Pathway | WP_MAPK_SIGNALING | 8.07e-04 | 246 | 87 | 7 | M39597 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 9.10e-04 | 70 | 87 | 4 | M3115 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 1.01e-03 | 72 | 87 | 4 | M39738 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EPHB2 EPHB3 EPHB4 EPHA6 RPS6KA5 DSCAML1 EGFR PIK3R1 EPHA7 EPHB1 | 1.03e-03 | 502 | 87 | 10 | MM14537 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 1.03e-03 | 8 | 87 | 2 | M47555 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING | 1.03e-03 | 8 | 87 | 2 | MM14532 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.07e-03 | 188 | 87 | 6 | MM15828 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 1.08e-03 | 33 | 87 | 3 | M39455 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.08e-03 | 126 | 87 | 5 | M45009 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.12e-03 | 74 | 87 | 4 | MM15962 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.18e-03 | 75 | 87 | 4 | M39568 | |
| Pathway | PID_EPHA_FWDPATHWAY | 1.18e-03 | 34 | 87 | 3 | M177 | |
| Pathway | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | 1.29e-03 | 35 | 87 | 3 | M127 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M22029 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.32e-03 | 9 | 87 | 2 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.32e-03 | 9 | 87 | 2 | MM15313 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 1.32e-03 | 9 | 87 | 2 | MM1551 | |
| Pathway | BIOCARTA_FEEDER_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M3061 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 1.32e-03 | 9 | 87 | 2 | MM15487 | |
| Pathway | PID_GMCSF_PATHWAY | 1.40e-03 | 36 | 87 | 3 | M22 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING | 1.64e-03 | 10 | 87 | 2 | M568 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 1.64e-03 | 10 | 87 | 2 | M47644 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.67e-03 | 205 | 87 | 6 | M752 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.72e-03 | 83 | 87 | 4 | M8728 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 1.72e-03 | 83 | 87 | 4 | M27163 | |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 6.79e-14 | 17 | 115 | 7 | 12217323 | |
| Pubmed | 9.54e-14 | 9 | 115 | 6 | 11403717 | ||
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 1.75e-13 | 19 | 115 | 7 | 12684176 | |
| Pubmed | 2.08e-13 | 83 | 115 | 10 | 11114734 | ||
| Pubmed | 4.02e-13 | 21 | 115 | 7 | 9267020 | ||
| Pubmed | 4.02e-13 | 21 | 115 | 7 | 11128993 | ||
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 4.02e-13 | 21 | 115 | 7 | 10730216 | |
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 4.02e-13 | 21 | 115 | 7 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 4.02e-13 | 21 | 115 | 7 | 20112066 | |
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 8.43e-13 | 23 | 115 | 7 | 19542359 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 1.19e-12 | 24 | 115 | 7 | 16446123 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | ERBB3 ERBB4 RPS6KA5 SGK1 IRAK2 ALPK1 STK32C MAST2 SGK3 EGFR PRKCB PRKCG PKN2 EPHB1 | 2.70e-11 | 372 | 115 | 14 | 22939624 |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 4.27e-11 | 20 | 115 | 6 | 11256076 | |
| Pubmed | 4.27e-11 | 20 | 115 | 6 | 10207129 | ||
| Pubmed | 4.27e-11 | 20 | 115 | 6 | 9530499 | ||
| Pubmed | 4.27e-11 | 20 | 115 | 6 | 9576626 | ||
| Pubmed | 4.51e-11 | 9 | 115 | 5 | 33253166 | ||
| Pubmed | 6.12e-11 | 40 | 115 | 7 | 30898150 | ||
| Pubmed | EphB signaling regulates target innervation in the developing and deafferented auditory brainstem. | 9.00e-11 | 10 | 115 | 5 | 22021100 | |
| Pubmed | 1.65e-10 | 11 | 115 | 5 | 22065784 | ||
| Pubmed | 3.69e-10 | 51 | 115 | 7 | 19769959 | ||
| Pubmed | 5.66e-10 | 5 | 115 | 4 | 10572067 | ||
| Pubmed | 7.08e-10 | 14 | 115 | 5 | 26941654 | ||
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 1.18e-09 | 33 | 115 | 6 | 26830346 | |
| Pubmed | 1.54e-09 | 16 | 115 | 5 | 8755474 | ||
| Pubmed | 3.94e-09 | 7 | 115 | 4 | 8954633 | ||
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 5.45e-09 | 42 | 115 | 6 | 11439183 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | EPHB2 EPHB4 RPS6KA5 MED16 SGK1 RETSAT TRRAP SGK3 TMX1 EGFR SH3PXD2A PKN2 OSTF1 DDX60L TAF1L MAST3 EPHA7 | 8.63e-09 | 910 | 115 | 17 | 36736316 |
| Pubmed | 1.41e-08 | 9 | 115 | 4 | 11580899 | ||
| Pubmed | EphB2 guides axons at the midline and is necessary for normal vestibular function. | 2.35e-08 | 10 | 115 | 4 | 10839360 | |
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 2.35e-08 | 10 | 115 | 4 | 17304517 | |
| Pubmed | 2.74e-08 | 143 | 115 | 8 | 20424473 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 17767505 | ||
| Pubmed | Completing the structural family portrait of the human EphB tyrosine kinase domains. | 3.52e-08 | 3 | 115 | 3 | 24677421 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 15488195 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 25051176 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 34296545 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 15722342 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 29731254 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 18424286 | ||
| Pubmed | Retinal axon growth cones respond to EphB extracellular domains as inhibitory axon guidance cues. | 3.52e-08 | 3 | 115 | 3 | 11532925 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 30637799 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 2173707 | ||
| Pubmed | Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus. | 3.52e-08 | 3 | 115 | 3 | 14691139 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 17289261 | ||
| Pubmed | A chemical genetic approach reveals distinct EphB signaling mechanisms during brain development. | 3.52e-08 | 3 | 115 | 3 | 23143520 | |
| Pubmed | EphB receptors couple dendritic filopodia motility to synapse formation. | 3.52e-08 | 3 | 115 | 3 | 18614029 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 35025117 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 22622783 | ||
| Pubmed | 3.68e-08 | 11 | 115 | 4 | 22171039 | ||
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 5.50e-08 | 12 | 115 | 4 | 21465626 | |
| Pubmed | 7.93e-08 | 13 | 115 | 4 | 12761849 | ||
| Pubmed | 1.32e-07 | 117 | 115 | 7 | 17145500 | ||
| Pubmed | Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay. | 1.41e-07 | 4 | 115 | 3 | 24557338 | |
| Pubmed | Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue. | 1.41e-07 | 4 | 115 | 3 | 23991224 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 20937870 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 22327010 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 17177598 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 21203579 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 19447869 | ||
| Pubmed | cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases. | 1.41e-07 | 4 | 115 | 3 | 7898931 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 18985033 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 23129351 | ||
| Pubmed | Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours. | 1.41e-07 | 4 | 115 | 3 | 20204273 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 27069134 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 26021752 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 16685269 | ||
| Pubmed | EphB2 receptor forward signaling controls cortical growth cone collapse via Nck and Pak. | 1.41e-07 | 4 | 115 | 3 | 23147113 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 9694886 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 22475621 | ||
| Pubmed | Eph receptor deficiencies lead to altered cochlear function. | 1.41e-07 | 4 | 115 | 3 | 12684184 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 22854050 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 9771475 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 15733067 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 8816440 | ||
| Pubmed | GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking. | 1.41e-07 | 4 | 115 | 3 | 15965473 | |
| Pubmed | 1.92e-07 | 75 | 115 | 6 | 15951569 | ||
| Pubmed | Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. | 2.61e-07 | 17 | 115 | 4 | 12971893 | |
| Pubmed | Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. | 3.35e-07 | 18 | 115 | 4 | 18651661 | |
| Pubmed | Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk. | 3.50e-07 | 5 | 115 | 3 | 10932185 | |
| Pubmed | An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells. | 3.50e-07 | 5 | 115 | 3 | 20227043 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 15682390 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 21278786 | ||
| Pubmed | Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer. | 3.50e-07 | 5 | 115 | 3 | 25416285 | |
| Pubmed | Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. | 3.50e-07 | 5 | 115 | 3 | 21559471 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 16843263 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 15254894 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 23137868 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 22554477 | ||
| Pubmed | Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway. | 3.50e-07 | 5 | 115 | 3 | 15524405 | |
| Pubmed | Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. | 3.50e-07 | 5 | 115 | 3 | 12646923 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 26886748 | ||
| Pubmed | Critical roles for EphB and ephrin-B bidirectional signalling in retinocollicular mapping. | 3.50e-07 | 5 | 115 | 3 | 21847105 | |
| Pubmed | Regulation of the ErbB3 binding protein Ebp1 by protein kinase C. | 3.50e-07 | 5 | 115 | 3 | 11325528 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 7589796 | ||
| Pubmed | 4.23e-07 | 19 | 115 | 4 | 35294885 | ||
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 15358134 | ||
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 29190819 | ||
| Pubmed | The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal Survival. | 6.99e-07 | 6 | 115 | 3 | 30083275 | |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 22439932 | ||
| Interaction | CDC37 interactions | EPHB2 EPHB4 ERBB3 EPHA6 RPS6KA5 SGK1 IRAK2 STK32C SGK3 EGFR PRKACG PRKCB PRKCG NAA40 EPHA5 EPHA7 EPHB1 | 1.14e-07 | 645 | 113 | 17 | int:CDC37 |
| Interaction | ABL2 interactions | 1.56e-07 | 107 | 113 | 8 | int:ABL2 | |
| Interaction | EFNB2 interactions | 1.44e-06 | 143 | 113 | 8 | int:EFNB2 | |
| Interaction | EPHB4 interactions | 1.69e-06 | 146 | 113 | 8 | int:EPHB4 | |
| Interaction | EFNA5 interactions | 2.24e-06 | 68 | 113 | 6 | int:EFNA5 | |
| Interaction | GRIN2B interactions | 5.24e-06 | 170 | 113 | 8 | int:GRIN2B | |
| Interaction | SOCS5 interactions | 9.13e-06 | 24 | 113 | 4 | int:SOCS5 | |
| Interaction | DUSP18 interactions | 9.13e-06 | 24 | 113 | 4 | int:DUSP18 | |
| Interaction | NCK1 interactions | 9.65e-06 | 244 | 113 | 9 | int:NCK1 | |
| Interaction | SEPTIN6 interactions | 1.01e-05 | 88 | 113 | 6 | int:SEPTIN6 | |
| Interaction | MUC4 interactions | 1.41e-05 | 9 | 113 | 3 | int:MUC4 | |
| Interaction | RIMS2 interactions | 1.49e-05 | 27 | 113 | 4 | int:RIMS2 | |
| Interaction | PTPN13 interactions | 1.85e-05 | 202 | 113 | 8 | int:PTPN13 | |
| Interaction | FES interactions | 2.35e-05 | 61 | 113 | 5 | int:FES | |
| Interaction | EFNA1 interactions | 2.50e-05 | 103 | 113 | 6 | int:EFNA1 | |
| Interaction | GRIN1 interactions | 2.60e-05 | 154 | 113 | 7 | int:GRIN1 | |
| Interaction | EGF interactions | 2.62e-05 | 31 | 113 | 4 | int:EGF | |
| Interaction | EPHB1 interactions | 2.62e-05 | 31 | 113 | 4 | int:EPHB1 | |
| Interaction | EPHB2 interactions | 2.98e-05 | 216 | 113 | 8 | int:EPHB2 | |
| Interaction | SH2B1 interactions | 2.99e-05 | 32 | 113 | 4 | int:SH2B1 | |
| Interaction | ILKAP interactions | 3.63e-05 | 110 | 113 | 6 | int:ILKAP | |
| Interaction | PTPN11 interactions | 4.27e-05 | 368 | 113 | 10 | int:PTPN11 | |
| Interaction | EPHA8 interactions | 4.72e-05 | 169 | 113 | 7 | int:EPHA8 | |
| Interaction | PTPN20 interactions | 5.97e-05 | 14 | 113 | 3 | int:PTPN20 | |
| Interaction | CCN2 interactions | 7.33e-05 | 40 | 113 | 4 | int:CCN2 | |
| Interaction | TNS4 interactions | 1.07e-04 | 44 | 113 | 4 | int:TNS4 | |
| Interaction | SHB interactions | 1.10e-04 | 84 | 113 | 5 | int:SHB | |
| Interaction | EPHA6 interactions | 1.17e-04 | 45 | 113 | 4 | int:EPHA6 | |
| Interaction | SH2D1A interactions | 1.17e-04 | 45 | 113 | 4 | int:SH2D1A | |
| Interaction | EHBP1 interactions | 1.23e-04 | 137 | 113 | 6 | int:EHBP1 | |
| Interaction | SHD interactions | 1.32e-04 | 18 | 113 | 3 | int:SHD | |
| Interaction | TEC interactions | 1.52e-04 | 90 | 113 | 5 | int:TEC | |
| Interaction | SOCS7 interactions | 1.63e-04 | 49 | 113 | 4 | int:SOCS7 | |
| Interaction | LYN interactions | EPHB3 ERBB3 ERBB4 IRAK2 GPRIN3 GPRIN1 TRIP10 TMX1 EGFR PIK3R1 PRKCB RNF180 EPHA7 | 1.99e-04 | 720 | 113 | 13 | int:LYN |
| Interaction | RET interactions | 2.01e-04 | 284 | 113 | 8 | int:RET | |
| Interaction | SH2D2A interactions | 2.06e-04 | 52 | 113 | 4 | int:SH2D2A | |
| Interaction | HSP90AA1 interactions | ERBB3 ERBB4 RPS6KA5 SGK1 IRAK2 SPG11 ALPK1 STK32C MAST2 SGK3 EGFR PRKACG LRP1 PRKCB PRKCG PKN2 NAA40 EPHB1 | 2.26e-04 | 1263 | 113 | 18 | int:HSP90AA1 |
| Interaction | VAV2 interactions | 2.38e-04 | 99 | 113 | 5 | int:VAV2 | |
| Interaction | CASR interactions | 2.45e-04 | 22 | 113 | 3 | int:CASR | |
| Interaction | SHC4 interactions | 2.45e-04 | 22 | 113 | 3 | int:SHC4 | |
| Interaction | ELF2 interactions | 2.50e-04 | 156 | 113 | 6 | int:ELF2 | |
| Interaction | PLCG2 interactions | 2.50e-04 | 100 | 113 | 5 | int:PLCG2 | |
| Interaction | VAV3 interactions | 2.56e-04 | 55 | 113 | 4 | int:VAV3 | |
| Interaction | LCP2 interactions | 2.56e-04 | 55 | 113 | 4 | int:LCP2 | |
| Interaction | NISCH interactions | 2.86e-04 | 160 | 113 | 6 | int:NISCH | |
| Interaction | TXK interactions | 2.94e-04 | 57 | 113 | 4 | int:TXK | |
| Interaction | ZFYVE16 interactions | 3.00e-04 | 104 | 113 | 5 | int:ZFYVE16 | |
| Interaction | GRAP2 interactions | 3.00e-04 | 104 | 113 | 5 | int:GRAP2 | |
| Interaction | MB21D2 interactions | 3.00e-04 | 104 | 113 | 5 | int:MB21D2 | |
| Interaction | FCGR1BP interactions | 3.08e-04 | 5 | 113 | 2 | int:FCGR1BP | |
| Interaction | CYFIP1 interactions | 3.11e-04 | 303 | 113 | 8 | int:CYFIP1 | |
| Interaction | WDR44 interactions | 3.13e-04 | 105 | 113 | 5 | int:WDR44 | |
| Interaction | RYR2 interactions | 3.15e-04 | 58 | 113 | 4 | int:RYR2 | |
| Interaction | PPM1A interactions | 3.16e-04 | 163 | 113 | 6 | int:PPM1A | |
| Interaction | SLA2 interactions | 3.19e-04 | 24 | 113 | 3 | int:SLA2 | |
| Interaction | PIK3R2 interactions | 3.19e-04 | 230 | 113 | 7 | int:PIK3R2 | |
| Interaction | PLEKHA5 interactions | 3.27e-04 | 231 | 113 | 7 | int:PLEKHA5 | |
| Interaction | NUMB interactions | 3.36e-04 | 232 | 113 | 7 | int:NUMB | |
| Interaction | DTX3 interactions | 3.57e-04 | 108 | 113 | 5 | int:DTX3 | |
| Interaction | RASA1 interactions | 3.60e-04 | 167 | 113 | 6 | int:RASA1 | |
| Interaction | SH2B3 interactions | 3.61e-04 | 25 | 113 | 3 | int:SH2B3 | |
| Interaction | SLC9A8 interactions | 3.61e-04 | 25 | 113 | 3 | int:SLC9A8 | |
| Interaction | HSH2D interactions | 3.61e-04 | 25 | 113 | 3 | int:HSH2D | |
| Interaction | EPHA3 interactions | 4.05e-04 | 111 | 113 | 5 | int:EPHA3 | |
| Interaction | ITK interactions | 4.07e-04 | 62 | 113 | 4 | int:ITK | |
| Interaction | LRIG1 interactions | 4.33e-04 | 63 | 113 | 4 | int:LRIG1 | |
| Interaction | GJA1 interactions | EPHB3 ERBB4 TAS1R3 GPRIN3 GPRIN1 NUP155 EGFR PIK3R1 CD2BP2 PRKCB PRKCG | 4.37e-04 | 583 | 113 | 11 | int:GJA1 |
| Interaction | PID1 interactions | 4.55e-04 | 27 | 113 | 3 | int:PID1 | |
| Interaction | STAP1 interactions | 4.55e-04 | 27 | 113 | 3 | int:STAP1 | |
| Interaction | NTRK2 interactions | 4.76e-04 | 176 | 113 | 6 | int:NTRK2 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 6.44e-14 | 14 | 77 | 7 | 1095 | |
| GeneFamily | Sterile alpha motif domain containing | 9.27e-08 | 88 | 77 | 7 | 760 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 2.96e-07 | 4 | 77 | 3 | 1096 | |
| GeneFamily | Fibronectin type III domain containing | 3.96e-07 | 160 | 77 | 8 | 555 | |
| GeneFamily | C2 domain containing protein kinases | 8.72e-06 | 10 | 77 | 3 | 835 | |
| GeneFamily | Low density lipoprotein receptors | 2.06e-05 | 13 | 77 | 3 | 634 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.80e-04 | 26 | 77 | 3 | 253 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 2.07e-03 | 16 | 77 | 2 | 173 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.66e-03 | 394 | 77 | 6 | 471 | |
| Coexpression | FIRESTEIN_PROLIFERATION | AKAP6 EPHB2 EPHB4 ERBB3 EPHA6 IRAK2 STK32C PIK3R1 PRKCG EPHB1 | 3.33e-09 | 166 | 115 | 10 | M5354 |
| Coexpression | DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY | 4.88e-06 | 26 | 115 | 4 | M16488 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 9.24e-06 | 64 | 115 | 5 | M1887 | |
| Coexpression | HALLMARK_ALLOGRAFT_REJECTION | 2.96e-05 | 200 | 115 | 7 | M5950 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 2.96e-05 | 200 | 115 | 7 | M6090 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 3.49e-05 | 84 | 115 | 5 | MM1049 | |
| Coexpression | KRAS.BREAST_UP.V1_DN | 4.10e-05 | 143 | 115 | 6 | M2887 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | CACNA1C CACNA1D CACNA1S ERBB3 ERBB4 HLA-E LCT ACE TRIP10 P3H4 CHRNB2 EGFR KCNQ3 PRKCB PYGM PRKCG KCNAB3 | 4.36e-05 | 1281 | 115 | 17 | M1884 |
| Coexpression | SEIDEN_ONCOGENESIS_BY_MET | 4.61e-05 | 89 | 115 | 5 | M3231 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 1.12e-07 | 147 | 115 | 7 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-07 | 179 | 115 | 7 | c815eb9f760fe4ca7a5e49beb224659f0b864f22 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-07 | 185 | 115 | 7 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.17e-07 | 189 | 115 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.02e-07 | 200 | 115 | 7 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-06 | 130 | 115 | 6 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-06 | 166 | 115 | 6 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 5.89e-06 | 173 | 115 | 6 | d4cbeae262abfa30d8c5452285d3261a96875610 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 180 | 115 | 6 | 0b653b1b653b40f3b8711d1312029a4a8a4961db | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.92e-06 | 186 | 115 | 6 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.77e-06 | 189 | 115 | 6 | f7d57723b8fb0f1e1485f51e3eff93ec0f39761e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-06 | 189 | 115 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-06 | 189 | 115 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 115 | 6 | 68ba1934b2b3f0cec8efd229fe1db6e8be8a26b0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-05 | 190 | 115 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 190 | 115 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 115 | 6 | 010d7d13a3c16e614c36720ef690a505b9f3f7aa | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.04e-05 | 191 | 115 | 6 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 191 | 115 | 6 | 5a5b5402a077b3189ca156f2bac5f47ad780aebf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 191 | 115 | 6 | 78bcce497920cc5b3bef083eab50deb1cc82cd2e | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 191 | 115 | 6 | 116fba9badea093e11f370996247cca0e4c02e8f | |
| ToppCell | proximal-Hematologic-Platelet/Megakaryocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-05 | 192 | 115 | 6 | 522d1bb15edf1d6006b80289bd3baadb99584ae8 | |
| ToppCell | proximal-3-Hematologic-Platelet/Megakaryocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-05 | 192 | 115 | 6 | f5f83dec37dff32a0c471cb05d23d13b0b0ad0c9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 192 | 115 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | proximal-Hematologic-Platelet/Megakaryocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-05 | 192 | 115 | 6 | 57899a905ca3e336bb7f31edc6418a2546b9891a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 193 | 115 | 6 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 197 | 115 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 198 | 115 | 6 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 198 | 115 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 198 | 115 | 6 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 1.27e-05 | 198 | 115 | 6 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-05 | 199 | 115 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 1.35e-05 | 200 | 115 | 6 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.45e-05 | 119 | 115 | 5 | d47880ef1cff036192c43646a04fa8598dd7e1f4 | |
| ToppCell | Striatum-Macroglia-ASTROCYTE|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.45e-05 | 119 | 115 | 5 | 0583387cc4497cf991fa42a81f2f66d9c6b774eb | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.57e-05 | 134 | 115 | 5 | a632d78890fcc20db81d2cf6b299470706d2e182 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.57e-05 | 134 | 115 | 5 | 8be2db71d9d29f9a57a64efdc89cf8c3e32b363b | |
| ToppCell | ASK454-Epithelial-Type_2|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.76e-05 | 136 | 115 | 5 | ff9a5e111993fdb3ac64c5ef269e3460ff994517 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.62e-05 | 144 | 115 | 5 | b638398f559e7fd9d4294d1c830beeb20f905960 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 145 | 115 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-05 | 157 | 115 | 5 | 0673c7161c25feceee8f1e5fd237171576c42c6b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-05 | 157 | 115 | 5 | d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.81e-05 | 159 | 115 | 5 | c64fff8d89f84d1f5a0cc432e31f56f741162505 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.34e-05 | 162 | 115 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 162 | 115 | 5 | 22f1abd20f43bc7e7fc46969da9962faf70ae5d2 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 162 | 115 | 5 | 966df4558140c3d541999ab553f201ae76a1c401 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 163 | 115 | 5 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 166 | 115 | 5 | 4b31d2755108b2815316411a38bfb11fd30ef98a | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.12e-05 | 166 | 115 | 5 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 167 | 115 | 5 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 167 | 115 | 5 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 167 | 115 | 5 | 3c4183a8225bae37b9f5341ebd1b95409ced2022 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 167 | 115 | 5 | 9480739587d51e67a281778b9bddd7b5ffc3ad92 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 167 | 115 | 5 | 28e9670586ff551b700c794313d27eedbfa1286b | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 168 | 115 | 5 | 3611605114f6b668b44728d6563cd02389e106af | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.53e-05 | 168 | 115 | 5 | 19d2c763b50e7168dfa7449fc407489b055526c2 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-mature_NK_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.53e-05 | 168 | 115 | 5 | fa198bd53b2d640d9a8684783bf5ca23314caae2 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 168 | 115 | 5 | 6c7b490b6c844d0ea4c07edfc24c02284f9533c4 | |
| ToppCell | facs-Marrow-Granulocytes-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 169 | 115 | 5 | ee1969755180df58d32904e2bb4192da9373d03e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.97e-05 | 170 | 115 | 5 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.97e-05 | 170 | 115 | 5 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.97e-05 | 170 | 115 | 5 | df1a34a69ae404c56f00751a01f52359535f5469 | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 8.42e-05 | 172 | 115 | 5 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 172 | 115 | 5 | 2dcc9d67d6ecc35940eabbc8ed528f5f884f6976 | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 172 | 115 | 5 | 64d2edbd8e2640b76225597883b1a524e6b1dd3b | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 172 | 115 | 5 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 172 | 115 | 5 | d061ea21bee179df5a525842e9a48621a8e1461b | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 173 | 115 | 5 | 25d72fa7a84baf5660ead6da67327590f5c91860 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 173 | 115 | 5 | 886ac1b98f709ad7131df778b83712bf8ed313de | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 175 | 115 | 5 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | facs-BAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 175 | 115 | 5 | 46d6e319f8ca46592f23257800bcb6d228fffbbe | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 176 | 115 | 5 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 176 | 115 | 5 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.38e-05 | 176 | 115 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.38e-05 | 176 | 115 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.63e-05 | 177 | 115 | 5 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-05 | 177 | 115 | 5 | 68f1139fc378f351e3b9e9f392aacb150025bf03 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-05 | 178 | 115 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.89e-05 | 178 | 115 | 5 | b863fc85d2449f25e6cea289459a7bb1f89583fd | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 179 | 115 | 5 | 898425fa81526a2e00fca7a25085229ff1f31069 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-3|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.02e-04 | 179 | 115 | 5 | f36776299e570345e18dc38cdef4cfc90e7ed7c2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-04 | 179 | 115 | 5 | 53e700494d251ec5649b2dea5fc7d5aeeeed572b | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 179 | 115 | 5 | 2fca4117c58824562ec80c7713fe15689a28efb3 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 1.02e-04 | 179 | 115 | 5 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 180 | 115 | 5 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-04 | 180 | 115 | 5 | f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 180 | 115 | 5 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.04e-04 | 180 | 115 | 5 | dcec59d66995f701d816eaeea3ed1439a2f71b73 | |
| ToppCell | Control-Myeloid-MoAM2|Control / Disease group,lineage and cell class （2021.01.30） | 1.04e-04 | 180 | 115 | 5 | 38892483a6a5388765aec87f0119c0b9bb5c7cbd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 181 | 115 | 5 | bad77767e64cc093a827a6b0f3f401f3f108e457 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-04 | 182 | 115 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 183 | 115 | 5 | 32880e71adba1b63fa9ec8530a8d4e46cc277c3a | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Lymphocytic-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 183 | 115 | 5 | 3b8f2b1df10c3543c7581493b531fe3fa40fe7fc | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 1.13e-04 | 183 | 115 | 5 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| Computational | Genes in the cancer module 80. | 2.68e-06 | 32 | 76 | 5 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 4.91e-06 | 36 | 76 | 5 | MODULE_51 | |
| Computational | Genes in the cancer module 85. | 2.82e-05 | 51 | 76 | 5 | MODULE_85 | |
| Computational | Porins / transporters. | 1.16e-04 | 211 | 76 | 8 | MODULE_63 | |
| Computational | Genes in the cancer module 267. | 1.45e-04 | 15 | 76 | 3 | MODULE_267 | |
| Computational | Genes in the cancer module 199. | 6.86e-04 | 57 | 76 | 4 | MODULE_199 | |
| Drug | myo-inositol | CACNA1C CACNA1D CACNA1S ERBB3 ERBB4 XDH CASR MINPP1 PITPNC1 LCT TRRAP CHRNA3 P2RX7 EGFR PIK3R1 PRKACG PRKCB PRKCG PKN2 GAST S1PR4 | 6.66e-10 | 811 | 115 | 21 | CID000000892 |
| Drug | vandetanib | 1.84e-09 | 99 | 115 | 9 | CID003081361 | |
| Drug | ponatinib | 1.90e-09 | 68 | 115 | 8 | ctd:C545373 | |
| Drug | noradrealine | CACNA1C CACNA1D CACNA1S SIGMAR1 CASR RRM1 ACE CHRNA3 CHRNB2 P2RX7 PIK3R1 PRKACG PRKCB PYGM PRKCG PKN2 GAST | 4.83e-09 | 575 | 115 | 17 | CID000000951 |
| Drug | AC1L1KC5 | CACNA1C CACNA1D CACNA1S ERBB3 ERBB4 CASR RRM1 CHRNA3 CHRNB2 TMX1 P2RX7 EGFR PIK3R1 PRKACG PRKCB PRKCG | 1.42e-08 | 541 | 115 | 16 | CID000005428 |
| Drug | Go6976 | 4.51e-08 | 190 | 115 | 10 | CID000003501 | |
| Drug | AC1L1JGQ | 8.63e-08 | 73 | 115 | 7 | CID000005034 | |
| Drug | verapamil | CACNA1C CACNA1D CACNA1S ACE CHRNA3 CHRNB2 TMX1 EGFR ABCD4 KCNQ3 PRKCB PRKCG PKN2 GAST | 1.86e-07 | 490 | 115 | 14 | CID000002520 |
| Drug | N-methyl-DL-aspartic acid | EPHB2 EPHB3 CACNA1C CACNA1D CACNA1S ERBB3 ERBB4 SIGMAR1 CHRNA3 CHRNB2 PIK3R1 PRKACG LRP1 PRKCB PRKCG PKN2 | 1.96e-07 | 655 | 115 | 16 | CID000004376 |
| Drug | tyrphostin 25 | 1.98e-07 | 122 | 115 | 8 | CID000002061 | |
| Drug | ethanol | CACNA1C CACNA1D ERBB3 ERBB4 SIGMAR1 XDH LCAT ACE CHRNA3 STAT1 CHRNB2 EGFR PIK3R1 TLR2 PRKACG PRKCB PRKCG PKN2 | 2.09e-07 | 837 | 115 | 18 | CID000000702 |
| Drug | lavendustin A | CACNA1C CACNA1D CACNA1S ERBB4 EGFR PIK3R1 PRKACG PRKCB PRKCG | 2.19e-07 | 171 | 115 | 9 | CID000003894 |
| Drug | EKB-569 | 2.92e-07 | 87 | 115 | 7 | CID006445562 | |
| Drug | sunitinib | 3.22e-07 | 130 | 115 | 8 | CID005329102 | |
| Drug | tetraethylammonium | CACNA1C CACNA1D CACNA1S SGK3 PRKACG KCNQ3 PRKCB PRKCG PKN2 GAST | 3.41e-07 | 236 | 115 | 10 | CID000005413 |
| Drug | carbachol | CACNA1C CACNA1D CACNA1S ERBB3 ERBB4 RPS6KA5 CHI3L1 CHRNA3 CHRNB2 EGFR PIK3R1 PRKACG PRKCB PRKCG PKN2 GAST | 3.78e-07 | 688 | 115 | 16 | CID000002551 |
| Drug | PD168393 | 5.00e-07 | 4 | 115 | 3 | CID000004708 | |
| Drug | amiloride | CACNA1C CACNA1D CACNA1S ERBB3 ERBB4 ACE SLC47A2 CHRNA3 EGFR PRKCB PRKCG | 5.92e-07 | 315 | 115 | 11 | CID000016230 |
| Drug | aldosterone | CACNA1C CACNA1D CACNA1S SGK1 CASR ACE CLDN8 SGK3 EGFR PRKCB PRKCG PKN2 | 8.21e-07 | 397 | 115 | 12 | CID000005839 |
| Drug | NSC618487 | CACNA1C CACNA1D DPT ERBB3 ERBB4 EPHA6 RPS6KA5 STAT1 EGFR PIK3R1 TLR2 PRKACG PRKCB PRKCG PKN2 EPHA5 EPHA7 EPHB1 | 1.01e-06 | 933 | 115 | 18 | CID000005279 |
| Drug | loperamide | 1.06e-06 | 105 | 115 | 7 | CID000003954 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA1C CACNA1D CACNA1S ERBB4 CASR MINPP1 ACE EGFR PRKACG PRKCB PYGM PRKCG PKN2 GAST | 1.09e-06 | 568 | 115 | 14 | CID000000806 |
| Drug | procaine | 1.11e-06 | 153 | 115 | 8 | CID000004914 | |
| Drug | Nisoldipine | 1.25e-06 | 5 | 115 | 3 | DB00401 | |
| Drug | RG 14921 | 1.25e-06 | 5 | 115 | 3 | CID000197517 | |
| Drug | 6-quinolinecarbaldehyde | 1.25e-06 | 5 | 115 | 3 | CID000765653 | |
| Drug | Nilvadipine | 1.25e-06 | 5 | 115 | 3 | DB06712 | |
| Drug | glutamate | EPHB2 SLC25A24 CACNA1C CACNA1D CACNA1S SIGMAR1 TAS1R3 SGK1 CHI3L1 CHRNA3 NDUFS3 CHRNB2 SGK3 P2RX7 PRKACG PRKCB PRKCG PKN2 | 1.56e-06 | 962 | 115 | 18 | CID000000611 |
| Drug | Barium | 1.73e-06 | 72 | 115 | 6 | ctd:D001464 | |
| Drug | AC1L1JVU | 1.73e-06 | 72 | 115 | 6 | CID000005229 | |
| Drug | imatinib | EPHB2 EPHB3 EPHB4 ERBB3 ERBB4 STAT1 EGFR PIK3R1 LRP1 EPHA5 EPHA7 EPHB1 | 1.89e-06 | 430 | 115 | 12 | CID000005291 |
| Drug | propranolol | CACNA1C CACNA1D CACNA1S LCAT CHRNA3 CHRNB2 PRKACG PRKCB PYGM PRKCG PKN2 GAST | 2.08e-06 | 434 | 115 | 12 | CID000004946 |
| Drug | TAPP-Br | 2.26e-06 | 19 | 115 | 4 | CID000160326 | |
| Drug | Cochliobolic acid | 2.48e-06 | 6 | 115 | 3 | CID006450172 | |
| Drug | CPU-23 | 2.48e-06 | 6 | 115 | 3 | CID003036051 | |
| Drug | SnCe6 | 2.48e-06 | 6 | 115 | 3 | CID000164259 | |
| Drug | diethyl ester | 2.48e-06 | 6 | 115 | 3 | CID000264327 | |
| Drug | methyl 2,5-dihydroxycinnamate | 2.58e-06 | 77 | 115 | 6 | CID000003248 | |
| Drug | fluo-3 | 2.90e-06 | 122 | 115 | 7 | CID000104978 | |
| Drug | AC1L1DXE | CACNA1C CACNA1D CACNA1S SIGMAR1 PIK3R1 PRKCB PYGM PRKCG PKN2 GAST | 2.90e-06 | 299 | 115 | 10 | CID000002548 |
| Drug | AC1L1DKK | 3.78e-06 | 127 | 115 | 7 | CID000002390 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.92e-06 | 181 | 115 | 8 | 1471_UP | |
| Drug | Amlodipine | 4.33e-06 | 7 | 115 | 3 | DB00381 | |
| Drug | Isradipine | 4.33e-06 | 7 | 115 | 3 | DB00270 | |
| Drug | RG 14467 | 4.33e-06 | 7 | 115 | 3 | CID000132069 | |
| Drug | SSFSB | 4.33e-06 | 7 | 115 | 3 | CID003035734 | |
| Drug | mangrove | LCAT LCT LRP1B CHRNA3 CHRNB2 PIK3R1 LRP1 LRP4 PRKCB PRKCG PKN2 GAST | 4.50e-06 | 468 | 115 | 12 | CID000000965 |
| Drug | Barium permanganate | 5.14e-06 | 133 | 115 | 7 | CID000024587 | |
| Drug | tetracaine | 5.63e-06 | 88 | 115 | 6 | CID000005411 | |
| Drug | mepivacaine | 5.88e-06 | 51 | 115 | 5 | CID000004062 | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 6.78e-06 | 195 | 115 | 8 | 6180_DN | |
| Drug | Nifedipine | 6.90e-06 | 8 | 115 | 3 | DB01115 | |
| Drug | Nitrendipine | 6.90e-06 | 8 | 115 | 3 | DB01054 | |
| Drug | CI-1033 | 7.12e-06 | 53 | 115 | 5 | CID000156413 | |
| Drug | AC1L1O6Q | 7.55e-06 | 141 | 115 | 7 | CID000058035 | |
| Drug | nicardipine | 9.07e-06 | 145 | 115 | 7 | CID000004473 | |
| Drug | GF109203X | ERBB3 ERBB4 RPS6KA5 EGFR PIK3R1 PRKACG PRKCB PRKCG PKN2 GAST | 9.23e-06 | 341 | 115 | 10 | CID000002396 |
| Drug | benzylidenemalononitrile | 9.91e-06 | 27 | 115 | 4 | CID000017608 | |
| Drug | Cinnarizine | 1.03e-05 | 9 | 115 | 3 | DB00568 | |
| Drug | Nimodipine | 1.03e-05 | 9 | 115 | 3 | DB00393 | |
| Drug | barium | 1.04e-05 | 148 | 115 | 7 | CID000104810 | |
| Drug | Hypertensin II | CACNA1C CACNA1D RPS6KA5 ACE LRP1B STAT1 EGFR PIK3R1 LRP1 PRKCB PRKCG | 1.15e-05 | 429 | 115 | 11 | CID000025476 |
| Drug | NCDC | 1.15e-05 | 28 | 115 | 4 | CID000001583 | |
| Drug | potassium | CACNA1C CACNA1D CACNA1S SGK1 ACE CHRNA3 CHRNB2 SGK3 P2RX7 PIK3R1 PRKACG KCNQ3 PRKCB PRKCG PKN2 GAST KCNAB3 | 1.23e-05 | 1008 | 115 | 17 | CID000000813 |
| Drug | monatepil | 1.33e-05 | 29 | 115 | 4 | CID000060810 | |
| Drug | chelerythrine | CACNA1C CACNA1D SIGMAR1 P2RX7 EGFR PIK3R1 PRKACG PRKCB PRKCG PKN2 | 1.37e-05 | 357 | 115 | 10 | CID000002703 |
| Drug | wartmannin | ERBB3 ERBB4 RPS6KA5 SGK1 MINPP1 STAT1 EGFR PIK3R1 TLR2 PRKACG PRKCB PRKCG PKN2 GAST S1PR4 | 1.45e-05 | 811 | 115 | 15 | CID000005691 |
| Drug | 6-(methylamino)pyrido(3,4-d)pyrimidine | 1.47e-05 | 10 | 115 | 3 | ctd:C107875 | |
| Drug | H 661 | 1.47e-05 | 10 | 115 | 3 | CID003056529 | |
| Drug | Pilocarpine | 1.47e-05 | 285 | 115 | 9 | ctd:D010862 | |
| Drug | Rc-3095 | 1.53e-05 | 30 | 115 | 4 | CID000122127 | |
| Drug | IBMX | 1.78e-05 | 368 | 115 | 10 | CID000003758 | |
| Drug | BAPTA-AM | 1.83e-05 | 293 | 115 | 9 | CID000002293 | |
| Drug | epicholesterol | DPT ERBB3 ERBB4 LCAT LCT ACE LRP1B CHRNA3 CHRNB2 EGFR TLR2 LRP1 LRP4 | 2.01e-05 | 636 | 115 | 13 | CID000000304 |
| Drug | Mibefradil | 2.01e-05 | 11 | 115 | 3 | DB01388 | |
| Drug | BE-23372M | 2.01e-05 | 11 | 115 | 3 | CID005311105 | |
| Drug | Felodipine | 2.01e-05 | 11 | 115 | 3 | DB01023 | |
| Drug | 4,5-dianilinophthalimide | 2.01e-05 | 11 | 115 | 3 | CID000001697 | |
| Drug | BIRB796 | 2.11e-05 | 66 | 115 | 5 | CID000156422 | |
| Drug | AC1L1FGW | 2.26e-05 | 33 | 115 | 4 | CID000003231 | |
| Drug | glibenclamide | CACNA1C CACNA1D SIGMAR1 ACE PRKACG ABCD4 KCNQ3 PRKCB PRKCG GAST | 2.45e-05 | 382 | 115 | 10 | CID000003488 |
| Drug | PD98059 | 2.46e-05 | 233 | 115 | 8 | CID000004713 | |
| Drug | vanadyl | 2.64e-05 | 307 | 115 | 9 | CID000061671 | |
| Drug | (2S,3R)-Sphingosine | ERBB3 ERBB4 CHRNA3 CHRNB2 EGFR PRKACG PRKCB PRKCG PKN2 S1PR4 | 2.86e-05 | 389 | 115 | 10 | CID000001104 |
| Drug | arabinosyladenine | AKAP6 EPHB4 CACNA1C CACNA1D SIGMAR1 XDH P2RX7 PIK3R1 PRKACG PRKCB PYGM PRKCG PKN2 GAST | 3.07e-05 | 762 | 115 | 14 | CID000000191 |
| Drug | Cocaine | EPHB2 EPHB3 EPHB4 RPS6KA5 SIGMAR1 SGK1 XDH TFIP11 ACE CHRNA3 CHRNB2 SGK3 EGFR ABCD4 PRKCB PRKCG EPHA5 EPHA7 EPHB1 | 3.10e-05 | 1314 | 115 | 19 | ctd:D003042 |
| Drug | halothane | 3.15e-05 | 314 | 115 | 9 | CID000003562 | |
| Drug | spermine | 3.19e-05 | 394 | 115 | 10 | CID000001103 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.30e-05 | 177 | 115 | 7 | 3462_UP | |
| Drug | isoproterenol | AKAP6 CACNA1C CACNA1D ACE CHRNA3 P2RX7 PIK3R1 PRKACG PRKCB PYGM PRKCG PKN2 GAST | 3.39e-05 | 669 | 115 | 13 | CID000003779 |
| Drug | 2nq6 | 3.46e-05 | 13 | 115 | 3 | CID011809364 | |
| Drug | SB203580 | AKAP6 ERBB3 ERBB4 RPS6KA5 STAT1 P2RX7 EGFR PIK3R1 TLR2 PRKACG PRKCB PRKCG PKN2 GAST | 3.49e-05 | 771 | 115 | 14 | CID000176155 |
| Drug | chrysarobin | 3.59e-05 | 37 | 115 | 4 | CID000068111 | |
| Drug | BAPTA | CACNA1C CACNA1D CACNA1S CHRNA3 P2RX7 PRKACG PRKCB PRKCG GAST | 4.02e-05 | 324 | 115 | 9 | CID000104751 |
| Drug | DFC-28 | 4.39e-05 | 14 | 115 | 3 | CID005743054 | |
| Drug | AC1L1JG6 | 4.39e-05 | 14 | 115 | 3 | CID000005026 | |
| Drug | PD153035 | 4.58e-05 | 127 | 115 | 6 | CID000004705 | |
| Drug | 2-aminoethyl diphenylborinate | 4.58e-05 | 127 | 115 | 6 | CID000001598 | |
| Drug | forskolin from Coleus forskohlii | AKAP6 CACNA1C CACNA1D SIGMAR1 XDH LCT CHRNA3 CHRNB2 EGFR PIK3R1 PRKACG PRKCB PRKCG PKN2 GAST EPHA5 | 5.01e-05 | 1013 | 115 | 16 | CID000003413 |
| Drug | 1-alpha-25-dihydroxycholecalciferol | CACNA1C CACNA1D CACNA1S ERBB3 ERBB4 RARRES1 RPS6KA5 IRAK2 CASR EGFR TLR2 PRKCB PRKCG ILDR1 PKN2 | 5.38e-05 | 909 | 115 | 15 | CID000002524 |
| Disease | Timothy syndrome (implicated_via_orthology) | 2.01e-07 | 4 | 110 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.75e-07 | 71 | 110 | 6 | DOID:0050700 (implicated_via_orthology) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 6.79e-07 | 19 | 110 | 4 | DOID:2876 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.26e-07 | 195 | 110 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | Schizophrenia | CACNA1C ERBB3 ERBB4 SIGMAR1 HLA-E SIRPB1 CHI3L1 ACE TRRAP CHRNA3 CHRNB2 SH3PXD2A TLR2 LRP1 KCNQ3 | 1.03e-06 | 883 | 110 | 15 | C0036341 |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.10e-06 | 49 | 110 | 5 | DOID:3910 (is_implicated_in) | |
| Disease | Adenocarcinoma of large intestine | 1.65e-06 | 96 | 110 | 6 | C1319315 | |
| Disease | Major Depressive Disorder | 3.75e-06 | 243 | 110 | 8 | C1269683 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 5.32e-06 | 31 | 110 | 4 | C1335167 | |
| Disease | gallbladder neoplasm | 8.14e-06 | 11 | 110 | 3 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 8.14e-06 | 11 | 110 | 3 | C0153452 | |
| Disease | Glycogen Storage Disease Type V | 1.38e-05 | 2 | 110 | 2 | C0017924 | |
| Disease | median neuropathy (biomarker_via_orthology) | 1.78e-05 | 14 | 110 | 3 | DOID:571 (biomarker_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 2.42e-05 | 45 | 110 | 4 | C0278701 | |
| Disease | renal fibrosis (implicated_via_orthology) | 3.30e-05 | 17 | 110 | 3 | DOID:0050855 (implicated_via_orthology) | |
| Disease | Juvenile amyotrophic lateral sclerosis | 4.12e-05 | 3 | 110 | 2 | cv:C3468114 | |
| Disease | Small cell carcinoma of lung | 5.01e-05 | 54 | 110 | 4 | C0149925 | |
| Disease | Unipolar Depression | 5.46e-05 | 259 | 110 | 7 | C0041696 | |
| Disease | Glioblastoma Multiforme | 6.15e-05 | 111 | 110 | 5 | C1621958 | |
| Disease | Bipolar Disorder | 7.67e-05 | 477 | 110 | 9 | C0005586 | |
| Disease | Juvenile amyotrophic lateral sclerosis | 8.22e-05 | 4 | 110 | 2 | C3468114 | |
| Disease | Staphylococcus aureus infection | 1.37e-04 | 5 | 110 | 2 | C1318973 | |
| Disease | Staphylococcal Infections | 1.37e-04 | 5 | 110 | 2 | C0038160 | |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 1.54e-04 | 28 | 110 | 3 | DOID:3083 (biomarker_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.78e-04 | 139 | 110 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | thigh muscle volume | 2.05e-04 | 6 | 110 | 2 | EFO_0020107 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.31e-04 | 32 | 110 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of lung | 2.31e-04 | 32 | 110 | 3 | C0149782 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.77e-04 | 447 | 110 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | blood urea nitrogen measurement | 2.99e-04 | 452 | 110 | 8 | EFO_0004741 | |
| Disease | Colorectal Carcinoma | 3.02e-04 | 702 | 110 | 10 | C0009402 | |
| Disease | lung disease (biomarker_via_orthology) | 3.02e-04 | 35 | 110 | 3 | DOID:850 (biomarker_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 3.29e-04 | 36 | 110 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | exudative vitreoretinopathy (implicated_via_orthology) | 3.80e-04 | 8 | 110 | 2 | DOID:0050535 (implicated_via_orthology) | |
| Disease | body weights and measures | 3.87e-04 | 38 | 110 | 3 | EFO_0004324 | |
| Disease | Disease Exacerbation | 3.92e-04 | 165 | 110 | 5 | C0235874 | |
| Disease | asthma, response to diisocyanate | 4.49e-04 | 261 | 110 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | Autistic Disorder | 4.49e-04 | 261 | 110 | 6 | C0004352 | |
| Disease | BRCA1 mutation carier status | 4.87e-04 | 9 | 110 | 2 | EFO_0011021 | |
| Disease | Gout | 4.87e-04 | 9 | 110 | 2 | C0018099 | |
| Disease | asthma | 5.12e-04 | 751 | 110 | 10 | MONDO_0004979 | |
| Disease | Alcoholic Intoxication, Chronic | 5.17e-04 | 268 | 110 | 6 | C0001973 | |
| Disease | 4-vinylphenol sulfate measurement | 6.08e-04 | 10 | 110 | 2 | EFO_0021149 | |
| Disease | Head and Neck Carcinoma | 6.08e-04 | 10 | 110 | 2 | C3887461 | |
| Disease | Malignant neoplasm of breast | AKAP6 EPHB4 ERBB3 ERBB4 KBTBD8 XDH UBLCP1 NDUFS3 STAT1 SGK3 EGFR DLEC1 | 6.75e-04 | 1074 | 110 | 12 | C0006142 |
| Disease | Berylliosis | 7.41e-04 | 11 | 110 | 2 | C0005138 | |
| Disease | Beryllium Disease | 7.41e-04 | 11 | 110 | 2 | C2350873 | |
| Disease | Stomach Neoplasms | 8.82e-04 | 297 | 110 | 6 | C0038356 | |
| Disease | pulmonary fibrosis (implicated_via_orthology) | 8.87e-04 | 12 | 110 | 2 | DOID:3770 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of stomach | 9.29e-04 | 300 | 110 | 6 | C0024623 | |
| Disease | lung disease (implicated_via_orthology) | 1.05e-03 | 13 | 110 | 2 | DOID:850 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.07e-03 | 206 | 110 | 5 | C0152013 | |
| Disease | colorectal cancer (is_implicated_in) | 1.11e-03 | 121 | 110 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | loneliness measurement | 1.22e-03 | 124 | 110 | 4 | EFO_0007865 | |
| Disease | hypertension (implicated_via_orthology) | 1.37e-03 | 128 | 110 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.60e-03 | 16 | 110 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | sarcoidosis (is_implicated_in) | 1.60e-03 | 16 | 110 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | triiodothyronine measurement | 1.60e-03 | 16 | 110 | 2 | EFO_0008392 | |
| Disease | hypertension (biomarker_via_orthology) | 1.64e-03 | 227 | 110 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | transitional cell carcinoma (is_marker_for) | 1.70e-03 | 63 | 110 | 3 | DOID:2671 (is_marker_for) | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.70e-03 | 63 | 110 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | carcinoma (implicated_via_orthology) | 1.78e-03 | 64 | 110 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Amyotrophic lateral sclerosis | 1.81e-03 | 17 | 110 | 2 | cv:C0002736 | |
| Disease | response to cyclophosphamide | 1.81e-03 | 17 | 110 | 2 | GO_1902518 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.92e-03 | 346 | 110 | 6 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Animal Mammary Neoplasms | 2.00e-03 | 142 | 110 | 4 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 2.00e-03 | 142 | 110 | 4 | C1257925 | |
| Disease | Adrenocortical carcinoma | 2.03e-03 | 18 | 110 | 2 | C0206686 | |
| Disease | parahippocampal gyrus volume measurement | 2.03e-03 | 18 | 110 | 2 | EFO_0010318 | |
| Disease | Alcohol abuse | 2.03e-03 | 67 | 110 | 3 | C0085762 | |
| Disease | Abdominal Aortic Aneurysm | 2.12e-03 | 68 | 110 | 3 | EFO_0004214 | |
| Disease | obesity (biomarker_via_orthology) | 2.27e-03 | 147 | 110 | 4 | DOID:9970 (biomarker_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 2.49e-03 | 72 | 110 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 2.49e-03 | 72 | 110 | 3 | DOID:9744 (is_marker_for) | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.50e-03 | 20 | 110 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of prostate | 2.50e-03 | 20 | 110 | 2 | C0007112 | |
| Disease | lung cancer (is_implicated_in) | 2.70e-03 | 74 | 110 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.70e-03 | 74 | 110 | 3 | DOID:3748 (is_marker_for) | |
| Disease | Mammary Neoplasms, Experimental | 2.75e-03 | 155 | 110 | 4 | C0024668 | |
| Disease | serum copper measurement | 2.76e-03 | 21 | 110 | 2 | EFO_0005267 | |
| Disease | Paroxysmal atrial fibrillation | 2.81e-03 | 156 | 110 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 2.81e-03 | 156 | 110 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.81e-03 | 156 | 110 | 4 | C2585653 | |
| Disease | cortical thickness | AKAP6 ERBB3 MAST2 STAT1 EGFR SH3PXD2A PIK3R1 LRP1 LRP4 DLEC1 EPHA7 | 2.97e-03 | 1113 | 110 | 11 | EFO_0004840 |
| Disease | Atrial Fibrillation | 3.08e-03 | 160 | 110 | 4 | C0004238 | |
| Disease | Lung Neoplasms | 3.20e-03 | 265 | 110 | 5 | C0024121 | |
| Disease | Malignant neoplasm of lung | 3.25e-03 | 266 | 110 | 5 | C0242379 | |
| Disease | Carcinomatosis | 3.29e-03 | 163 | 110 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 3.29e-03 | 163 | 110 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 3.29e-03 | 163 | 110 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 3.29e-03 | 163 | 110 | 4 | C0205696 | |
| Disease | Carcinoma | 3.36e-03 | 164 | 110 | 4 | C0007097 | |
| Disease | stomach carcinoma (is_marker_for) | 3.60e-03 | 24 | 110 | 2 | DOID:5517 (is_marker_for) | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.66e-03 | 670 | 110 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | Mood Disorders | 3.66e-03 | 168 | 110 | 4 | C0525045 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IMDEDGYFWWSGRVD | 456 | Q6P461 | |
| QSDVWSYGVTVWELM | 891 | P21860 | |
| SDVWSYGVTIWELMT | 901 | Q15303 | |
| SVNNNWIDLYMWVEE | 86 | A6NF34 | |
| WIDLYMWVEETVARF | 91 | A6NF34 | |
| MNLKDYWESGEWAII | 196 | P32297 | |
| LLGDMWAQSWENIYD | 281 | P12821 | |
| MQMEEYRGWVEWIEN | 86 | Q9UIR0 | |
| AMADIIEYFRWNWVG | 196 | P41180 | |
| TSASDVWSYGIVMWE | 856 | P54756 | |
| DKWYWTGDVATMNEQ | 486 | Q96CM8 | |
| WWEEINRAGMEWYQT | 91 | Q07507 | |
| VDWNWYDVLSPGEMQ | 516 | O14678 | |
| WDLYVWDEEQEEMAL | 296 | A1A5B4 | |
| KLGMWYEAAELIWAS | 206 | Q96QP1 | |
| DVWSYGIVMWEVMSF | 806 | P54762 | |
| PWMEQEGSEYWDRET | 71 | P13747 | |
| DMGWDDWIIAPLEYE | 411 | P43026 | |
| WEYIGRKMDVADFEW | 51 | Q9HCP6 | |
| VVDPVNGWMYWTDWE | 651 | Q9NZR2 | |
| NGWMYWTDWEEDEID | 656 | Q9NZR2 | |
| SDAWSYGIVMWEVMS | 801 | P54760 | |
| WDWMEFASYVITDLT | 26 | O43187 | |
| GVAVDWMGDNLYWTD | 606 | Q07954 | |
| MKEEFETYADALWWG | 296 | O43525 | |
| IQLYDTMAQVWETWP | 1011 | Q5H9U9 | |
| IDTWEWNDVTLYGML | 66 | P36222 | |
| ASDVWSYGIVMWEVM | 806 | P29323 | |
| EWMVHGYPSENVWEL | 401 | Q8NCN5 | |
| RKMTVWGEVWENAVY | 181 | Q9H0B8 | |
| VINEVMWWDHGVYYC | 131 | Q86SU0 | |
| LRGYTVWSAMDNFEW | 1786 | P09848 | |
| MEGHVYWTDDEVWAI | 1 | A4QPB2 | |
| MEATLWIGLRWTAYE | 1006 | O60449 | |
| TSASDVWSYGIVMWE | 816 | P54753 | |
| VDWWSLGVLMYELLT | 236 | O75582 | |
| SVDWWAFGVLLYEML | 521 | P05771 | |
| VDWWSFGVLLYEMLA | 536 | P05129 | |
| MSLQDAEWYWGDISR | 326 | P27986 | |
| ASDVWSYGIVMWEVM | 816 | Q15375 | |
| WENDGGAWTAYDMDI | 111 | Q86Y01 | |
| MTDDRAWYLIAWENS | 101 | Q86UY6 | |
| DRLWEMYINWENEQG | 206 | Q86UA1 | |
| WLTIDSDIFMWNYED | 116 | O75694 | |
| DQWMKVYETPDRLWD | 566 | Q8NFY9 | |
| CMVTGYDWWDILLHV | 481 | Q9Y2X0 | |
| DMDTSDTQWGWFYLA | 26 | Q9NR21 | |
| IMGIEIYWDCNLDRW | 251 | Q99572 | |
| DGLVDVMWEYKWENT | 276 | O95400 | |
| VMWEYKWENTGDAEL | 281 | O95400 | |
| QGPWLEEEEEAYGWM | 76 | P01350 | |
| DVWSYGVTVWELMTF | 896 | P00533 | |
| DWWALGVLIYEMAVG | 221 | P22612 | |
| TMEGWTDVLYWVNDA | 361 | Q13936 | |
| MEGWTDVLYWVNDAI | 291 | Q13698 | |
| WSLYVDGEWGEMQNI | 1131 | Q8TD84 | |
| LQIAAMWKEDTGSYW | 71 | Q96LA6 | |
| VDWWAMGIILYEFLV | 706 | Q6P0Q8 | |
| VDWWAMGVVLYEFLV | 561 | O60307 | |
| SVGYQHDMIVNVWAW | 151 | O60336 | |
| FEEGWYMWLQSRDLL | 311 | P04180 | |
| RDVSWDEKGMTWEVY | 911 | Q7Z2K8 | |
| DVRWDAEGMTWEVYG | 381 | O60269 | |
| WDEQGMTWEVYGASL | 686 | Q6ZVF9 | |
| MWGEYWDNLICTVGD | 1211 | Q9Y238 | |
| WAQEYLRGMDWILAL | 281 | O95977 | |
| TVDWWCLGAVLYEML | 341 | Q96BR1 | |
| ITMEGWTDVLYWMND | 361 | Q01668 | |
| WTDVLYWMNDAMGFE | 366 | Q01668 | |
| GDIIYITDMSDTNWW | 36 | Q92882 | |
| SRGWWFDMDMVIIYI | 556 | Q86T96 | |
| ASDAWSYGIVMWEVM | 856 | Q9UF33 | |
| WGTSRWGAAEIMEAY | 226 | O43448 | |
| IMLIPTAYEWFEEWQ | 461 | Q6NUM9 | |
| SGWASILWYNMLVAE | 466 | P42224 | |
| MICVEWWAYEIGSFL | 301 | Q86VL8 | |
| YGRWEDNIIWDAQAM | 496 | Q8IZX4 | |
| KAANWYEREIWDMFG | 161 | O75489 | |
| RTVDWWCLGAVLYEM | 276 | O00141 | |
| DEELQWVFVNAGGWM | 76 | Q99720 | |
| MFDIKAWAEYVVEWA | 1 | Q7Z3B0 | |
| EWDWKLLTYVMEEEG | 546 | Q8NDZ2 | |
| ENSWNEEEVWRIEMY | 346 | Q8NFT2 | |
| RAVDWWGLGVLIYEM | 836 | Q16513 | |
| CVFVVIWWYMDEGLL | 66 | Q92535 | |
| SWVEKMEEGNSRCWY | 181 | Q9NRX5 | |
| VDWWSVGVMAYELLR | 276 | Q86UX6 | |
| IMTTNVWLTQEWEDY | 76 | P17787 | |
| SEYQELWDWLIDMES | 966 | Q13023 | |
| VVFENFWEGLWMNCV | 41 | P56748 | |
| MDWGTELWDQFEVLE | 1 | Q15642 | |
| LIENKDGTYNWMSWL | 301 | O00241 | |
| WEVERMGYTITLWDL | 441 | Q96JI7 | |
| ITNWDNVDYMWDEEE | 111 | Q96A61 | |
| DMEYDLKLWVWQGSV | 451 | Q7RTX0 | |
| VVPMEDVAWEYKWEL | 131 | Q6AZZ1 | |
| RAWEEQYQWDVEDMK | 306 | P17040 | |
| LWYADWMDGQLVEKG | 136 | Q9UNW1 | |
| QMEEADDWLRYGNPW | 176 | P11217 | |
| LQYDMWNVTPTDLWD | 566 | P23921 | |
| VSMEVLERNPNGWWY | 1096 | Q5TCZ1 | |
| EGDYEEGMYADWWQE | 406 | Q92791 | |
| WETWQNEFAGIEMTY | 1346 | Q9BX26 | |
| AWVDEWYDMTMDEVR | 221 | Q9UKF7 | |
| NGDMYCIWELIFIWS | 291 | Q8IZM8 | |
| SGSWEDWVTAAYMDT | 1111 | P47989 | |
| GVWTYEQELMVPVQW | 111 | O95859 | |
| MARNDLWYLSLEEVW | 116 | P21506 | |
| DYDIVIWSATNMKWI | 176 | Q8WVY7 | |
| SLIMDWWYNAEKDGD | 701 | Q502W6 | |
| IWDLAFLGSSYVMWE | 191 | P49788 | |
| YLEWPMDEAQREGFW | 761 | O60603 | |
| ELLEGDWMIEFYAPW | 41 | Q9H3N1 | |
| LYSLLQEEDMWAGLW | 2751 | Q9Y4A5 | |
| VLVKAWAMWGDYLEN | 3151 | Q9Y4A5 | |
| WAMWGDYLENIFVKE | 3156 | Q9Y4A5 | |
| VDGTMTVDWNEWRDY | 136 | Q6NUK1 | |
| HMDAFYWVIDWEGMI | 631 | Q9UBB9 | |
| YWVIDWEGMISVSSL | 636 | Q9UBB9 | |
| IIWDALDWTMQAYER | 246 | Q9HAD4 | |
| WMENLIQRYIWDGES | 936 | Q5VV43 | |
| MYWTDWGENAKLERS | 1181 | O75096 |